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3Abstract
Self-nonself discrimination is the basic property of the immune system that
allows rejection of pathogens without attacking self-specific structures.
Discrimination of self and nonself is based on both structural features of the antigen
as well as on the context, in which the antigen is encountered. While specific
recognition of nonself-antigens in presence of microbial products induces potent
immune responses, several suppressing mechanisms exist that limit immune reactions
to specifically recognized antigens in a context devoid of microbial agents.
A prominent example of suppressing mechanisms is regulation of T cell
responses by regulatory T cells (Tregs). Treg-mediated suppression is induced upon T
cell receptor (TCR) stimulation of Tregs and therefore dependent on Treg specificity.
We found that TCRs derived from mouse regulatory and conventional T cells cover a
similar spectrum of affinity towards self-antigens, which implies that Tregs express a
similar TCR repertoire as conventional T cells. This result suggests that Treg-
mediated suppression is not induced by recognition of self-antigen but rather
regulated by recognition of the immunological context.
Characterization of Treg function in autoimmune diseases is hampered by the
fact that Tregs in an inflamed tissue cannot be discriminated from infiltrating
activated conventional T cells. We report that at the site of autoimmune reactions
Tregs can be distinguished from activated T cells by the expression of CD27. Using
this novel Treg marker we show that the suppressive activity of Tregs isolated from
inflamed tissues is not limited in vitro, which precludes a Treg-intrinsic defect.
However we have observed that cytokines as IL-7 and IL-15, which are present in the
autoimmune inflammatory milieu, potently block Treg-mediated suppression in vitro.
These results suggest that in vivo IL-7 and IL-15 may interfere with Treg function at
the sites of ongoing autoimmune reactions.
Recognition of a context containing signs of microbial invasion leads to the
counterbalancing of suppressing mechanisms and to the induction of potent immune
responses. Such a context is characterized by the presence of pathogen-associated
molecular patterns (PAMPs) that are recognized by Toll-like receptors (TLRs)
expressed on a variety of cell types. We show that TLR triggering is critically
required for the induction of productive T-dependent human naïve B cell responses. B
                                                                                                                            Abstract
4
cell receptor (BCR) triggering and T cell help induced initial B cell proliferation but
were not sufficient to sustain prolonged survival and accumulation of B cells.
Extensive proliferation, isotypic switch and differentiation to Ig-secreting cells were
promoted by microbial agents acting on TLRs expressed by naïve B cells upon BCR
stimulation. This finding demonstrates that humoral immune responses (as cellular
immune responses) are critically dependent on context discrimination via detection of
PAMPs.
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7Abbreviations
AID activation induced cytidine deaminase
AIRE autoimmune regulator
APC antigen presenting cell
BCR B cell receptor
CFA complete Freud’s adjuvants
CFSE Carboxy-fluorescein diacetate succinimidyl ester
DC dendritic cell
IFN interferon
Ig immunoglobulin
IL interleukin
JIA juvenile idiopathic arthritis
LPS lipopolysaccharide
MHC major histocompatibility complex
PAMP pathogen-associated molecular patterns
PB peripheral blood
PBMC peripheral blood mononuclear cells
PI propidium iodide
PRR pattern-recognition receptor
SF synovial fluid
SFMC synovial fluid mononuclear cells
TLR Toll-like receptor
Treg regulatory T cells
Xbp-1 X-box binding protein 1
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Introduction
The function of the immune system is the protection of the organism from
invasion of harmful pathogens. The essential prerequisite for this task is the ability to
reliably discriminate between self and nonself in order to allow elimination of
intruders without attacking self-structures. Self-nonself discrimination occurs at the
level of both the antigen and the context, in which the antigen is encountered.
At the level of the antigen, self-nonself discrimination is mediated by specific
deletion or inactivation of self-reactive cells. A reduction of the pool of self-reactive
cells is primarily achieved by mechanisms of central tolerance. During T-cell
development, thymocytes bearing T cell receptors (TCRs) of high-affinity for self-
antigens are eliminated through negative selection, while thymocytes with TCRs of
low to intermediate affinity to self-antigens are allowed to continue maturation 1-3. A
key function for negative selection has been attributed to the transcription factor
AIRE, which induces the promiscuous expression of tissue-specific antigens by
thymic epithelial cells (TECs) and thus enables the thymic deletion of T cells reactive
to peripheral antigens 4,5 (Fig. 1). Similarly, maturation of B cells is critically
dependent on the avidity of the B cell receptor (BCR) to self-antigens. Developing B
cells that recognize self-antigens expressed in the bone marrow are induced to
undergo receptor editing and alter their specificity by exchanging the immunoglobulin
(Ig) light chain. Immature B cells that do no succeed in converting self-reactive into
nonself-reactive surface Ig die by apoptosis through negative selection 6,7.
The mechanisms of central tolerance purge the pool of lymphocytes from
highly autoreactive cells, but are nevertheless not sufficient to confer absolute
protection from autoimmunity, as cells of intermediate affinity towards self-antigens
escape negative selection and complete maturation. Indeed, three additional fail-save
mechanisms of peripheral tolerance exist that prevent autoimmunity by controlling
self-antigen induced immune responses in the periphery (Fig. 1). The first mechanism
is based on ignorance of antigens that are expressed at a very low level or that are
sequestered from recirculating cells by means of structural barriers. Ignorance is not a
permanent way of inducing tolerance as lymphocytes specific for these antigens
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persist and pose a potential threat in altered circumstances characterized by increased
expression of the antigen or accidental breakage of the structural barrier 8. The second
mechanism consists in induction of anergy and deletion of self-reactive lymphocytes
that repeatedly encounter their antigen in a non-inflammatory environment. Anergic
cells are in a state of hypo-responsiveness to antigenic stimulation, have lost the
ability to mount a productive immune response and are prone to die 9,10. The third
mechanism to control autoimmunity is imposed by regulatory T cells (Tregs, see
below). Tregs suppress CD4+ T cell activation and expansion via direct cell-cell
interactions. Elimination of Tregs immediately after birth or inherited lack of Tregs
leads to severe autoimmune diseases 11-13.
The second factor enabling self-nonself discrimination is recognition of the
context, in which an antigen is encountered. Context discrimination impacts on the
decision whether antigen-specific activation results in productive or in abortive
immune responses (Fig. 1). Reliable detection of microbial invasion is enabled by
recognition of pathogen-associated molecular patterns (PAMPs), which include a
large panel of molecular structures that are characteristic for microbial species while
being absent from body tissues. PAMPs are generally recognized by receptors of the
innate immune system (see below) 14. Triggering of innate receptors by PAMPs
induces in the immune system a state of increased alert, promotes a crosstalk between
the innate and the adaptive immune system 15 and provides enhancing stimuli capable
of counterbalancing the above-mentioned suppressive mechanisms. For instance in
the case of ignored antigens a breakage of the structural barrier does not automatically
lead to autoimmunity. Rather it has been shown that autoreactive cells gaining sudden
access to their previously sequestered antigen do not start autoimmune reactions
unless PAMPs are present. PAMPs induce an inflammatory status of the target organ,
which leads to productive T cell priming followed by destruction of the target organ16.
Similarly, for freely accessible antigens the presence of microbial products impacts on
the decision whether stimulation of T cells results in activation or anergy 17. Self-
antigen presenting immature dendritic cells (DCs), present only in a context devoid of
any signs of danger, stimulate T cells in a suboptimal way that results in anergy of
interacting self-antigen specific T cells. In contrast, upon detection of a context of
danger and uptake of foreign antigen, nonself-antigen presenting mature DCs express
costimulatory molecules and are able to induce productive priming of nonself-specific
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T cells. And finally, the responsiveness of T cells to Treg-mediated suppression is
severely reduced in presence of PAMPs that induce DC maturation. Upon maturation,
DCs express costimulatory molecules and produce IL-6 and in this way render T cells
insensitive to suppression by Tregs 12,18.
Thus dual recognition of both structural features of the antigen and the
presence of microbial products in the milieu, in which the antigen is encountered,
enables reliable discrimination between self and nonself. Suppressing and enhancing
mechanisms counterbalance each other in order to modulate antigen-specific
activation in periphery. Accurate balance between these opposing forces is of great
importance as every disturbance of the optimum can lead to either unsuccessful
elimination of invading pathogens or to induction of exacerbated responses leading to
autoimmune diseases.
Figure 1. Control of immune responses by recognition of antigen and context. Combinatorial production of
antigen-specific receptors generates a large variety of nonself- and self-specific lymphocytes. This initial pool is
purged from highly autoreactive cells by mechanisms of central tolerance. In the periphery, immune responses
are controlled by recognition of both the antigen and the context, in which the antigen is encountered. Immune
responses to self-antigens in a non-inflammatory context are limited by mechanisms of peripheral tolerance that
include ignorance, anergy and Treg-mediated suppression. Inflammation produces enhancing signals capable of
counterbalancing the above mentioned suppressing mechanisms and leads to induction of potent immune
responses against invading pathogens.
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Suppression of T cell responses by naturally arising regulatory T
cells
Naturally arising regulatory T cells
The first results pointing to a role for T-cell mediated control of T cell
responses were obtained from studies on lymphopenia-driven T cell expansion.
Reconstitution of athymic nude mice with CD4+CD25- T cells resulted in
development of severe and multiple autoimmune diseases. In contrast, when total
CD4+ T cells or CD4+CD25+ T cells were co-injected, T cells expanded in a
controlled way, and mice were protected from autoimmunity 19. This seminal study
first identified the T cell subset characterized by expression of CD4 and CD25 as
being responsible for the regulation of T cell responses.
Based on their regulatory function CD4+CD25+ T cells were defined as
naturally arising regulatory T cells 11-13. CD4+CD25+ Tregs constitute 5-10% of
circulating CD4+ in healthy individuals and are characterized by the expression of
several additional surface markers as CTLA-4, GITR, and - at least in mice -
neuropilin-1. They show a typical anergic behavior and proliferate only in the
presence of strong stimuli and upon addition of exogenous IL-2. CD4+CD25+ Tregs
are not able to produce Th1 or Th2 cytokines upon activation, instead they produce
suppressive cytokines as IL-10 and TGF-beta.
CD4+CD25+ Tregs arise in the thymus 20, and neonatal thymectomy has been
shown to reduce the amount of Tregs in periphery resulting in autoimmune diseases
21,22. The master regulator for the induction of the Treg phenotype is the transcription
factor Foxp3, and transduction of Foxp3 into naïve T cells induces a Treg phenotype
23,24. Besides naturally arising Tregs, other regulatory subsets exist that are induced
upon several different in vitro and in vivo treatments 25-31.
The main function of Tregs seems to be the limitation of CD4+ T cell
proliferation by a yet unknown contact-dependent and cytokine-independent
mechanism induced upon TCR stimulation of Tregs. Treg suppressor activity has
been demonstrated both in vitro, where Tregs efficiently suppress CD4+ T cell
proliferation and cytokine production, and in vivo, where they control lymphopenia-
driven proliferation and expansion of CD4+ T cells 32.
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The specificity of regulatory T cells
One issue that has gained much interest is the determination of Treg
specificity. As suppressor activity is only induced upon TCR stimulation of Tregs,
determination of Treg specificity will lead to a better understanding of the conditions
under which Tregs exert their function - an essential prerequisite for the development
of therapeutic applications.
The current hypothesis suggests that Tregs may function in the maintenance
of self-tolerance by specifically suppressing the activation of autoreactive T cells.
Treg could be activated by autologous DC and then suppress the response of nearby
conventional autoreactive CD4+ T cells. This theory demands that Tregs can be
activated by autologous cells and thus bear TCR of increased affinity for self-antigens
33.
Research on the specificity of Tregs is hampered by the anergic behavior of
Tregs that precludes a direct measurement of responses to self-antigen bearing APC.
Several attempts were made to directly measure the response of Tregs to autologous
APCs in presence of high amounts of exogenous IL-2, which is reported to abrogate
their anergic behavior 34-36. Although none of the studies found any substantial
increase in activation or proliferation of Treg as compared to normal CD4+ T cells, it
is difficult to conclude from these negative results that Treg are not autoreactive.
There is indeed indirect evidence that the development of Tregs might be
linked with the expression of TCRs of increased affinity towards self. The
development of cells belonging to the Treg lineage seems to be critically dependent
on TCR-antigen interaction in the thymus 37-39, mediated by MHC II-expressing
thymic epithelial cells (TECs) 40. These observations point to a role for self-antigen in
induction of the Treg lineage.
Alternatively, it has been postulated that a selective rather than an instructive
process shapes the repertoire of Treg 41. CD4+CD25+ thymocytes have been shown to
be much less sensitive to agonist-induced clonal deletion than CD4+CD25-
thymocytes suggesting a higher threshold for negative selection in the CD4+CD25+
thymic population. Also this finding implies that the final population of CD4+CD25+
Tregs might contain cells of higher affinity towards self-antigens because of a
reduced negative selection process.
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A more direct evidence for the prevalence of TCRs of higher affinity towards
self in the mature Treg compartment comes from a recent study where a limited
number of TCRs from CD4+CD25+ and CD4+CD25- was cloned and introduced into
naïve CD4+ T cells by retrovirus-mediated gene transfer 42. When these cells
expressing now two TCR were injected into lymphopenic mice, TCRs from
CD4+CD25+ T cells conferred a greater proliferative advantage for expansion of these
cells than TCR from CD4+CD25-, again suggesting a higher frequency of self-reactive
TCRs in the Treg population.
But the model of self-reactive Treg that are activated specifically by
autologous immature APC and suppress self-antigen induced T cell proliferation is
challenged by recent findings. The retroviral transduction of normal naïve CD4+ T
cells with the Foxp3 transgene resulted in the acquisition of a Treg phenotype that
included expression of CD25, anergic behavior and exertion of suppressor activity
comparable to naturally arising Tregs 23,24. These induced Tregs derived from a
normal pool of naïve CD4+ T cells that had undergone thymic negative selection, and
therefore they were not supposed to be autoreactive - but nevertheless they
successfully suppressed T cell responses. This result poses into question the model of
self-reactivity in the Treg compartment and postulates that a potential shift in affinity
to self-antigens between normal and regulatory T cells is of no importance for the
process of suppressing T cell responses.
Identification and function of regulatory T cells in autoimmune
diseases
Another therapeutically important issue that remains to be addressed is the
determination of the role Tregs play in vivo in the control of autoimmune diseases.
CD4+CD25+ cells can indeed be detected in inflamed tissues of patients suffering
from autoimmune diseases as juvenile idiopathic arthritis (JIA) and seem to exert
some Treg function ex vivo 43-46. However several other studies suggested an intrinsic
defect in Treg activity as driving mechanism for the development of autoimmune
diseases 47-49. In addition, the function of Tregs in limiting ongoing autoimmune
responses seems to be reduced by a nonresponsiveness of proliferating autoreactive T
cells either due to their preactivated state 50 or due to the inflammatory milieu
                                                                                                                      Background
14
containing cytokines as IL-2 12 or IL-6 18. These findings point to a link between Treg
activity and development of autoimmune diseases.
Most ex vivo studies on Tregs in autoimmune diseases were performed on
CD4+CD25+ T cells isolated from the inflamed tissue. But the identification of
regulatory T cells in pathologic conditions is complicated by the fact that all Treg
markers, including CD25, are also expressed on activated T cells that accumulate at
the site of chronic inflammation. It is therefore not possible to discriminate in an
ongoing immune response regulatory from activated effector T cells on the base of the
known Treg markers, and a possible heterogeneity of the CD4+CD25+ subset in
inflamed tissues has not been addressed so far.
Context discrimination by innate immunity and its effect on B cell
responses
Toll-Like Receptors
The innate immune system plays an important role in the immediate
recognition and elimination of pathogens and acts therefore as a first line of defense
against microbial invasion 14,15. Moreover, upon activation the innate immune system
interacts with the adaptive immune system and delivers essential stimulatory signals
for induction and sustaining of adaptive immune responses 14,15. As it acts as a potent
inductor of adaptive immune responses, the innate immune system must be endowed
with the ability to discriminate between self and nonself.
Key components of the innate immune system are pattern-recognition
receptors (PRRs) that sense the presence of invading pathogens by recognizing
conserved PAMPs. The best-characterized member of PPR is the family of TLRs 14,15
(Fig. 2). Until now there are 11 known TLRs in mammalians that detect various
pathogen-derived conserved structures as bacterial lipoproteins (TLR2 and 6), dsRNA
(TLR3), LPS (TLR4), flagellin (TLR5), ssRNA (TLR7 and 8) and unmethylated
CpG-DNA (TLR9). TLR triggering induces signaling through the common adaptor
protein MyD88 ultimately leading to the activation of NF-kB. Only TLR3 binding
activates an alternative pathway that promotes production of IFNbeta and thus
induces a different set of genes. Interestingly, TLR4 can signal through both MyD88-
dependent and –independent pathways.
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TLRs are expressed on a variety of cell types including DC and other cells
from the innate (neutrophils, eosinophils, mast cells) and adaptive (B cells, T cells)
immune system as well as on stromal cells 14,15. Every cell type expresses a
characteristic set of TLRs, and this differential expression pattern combined with the
narrow ligand specificity of every single TLR and the diverse signal transduction
pathways induced by different TLRs allows to evoke a large spectrum of possible
responses to a variety of different PAMPs.
Different mechanisms ensure that TLRs are activated only in presence of
pathogen-derived structures; these mechanisms are mainly dependent on the exact
cellular localization of the TLRs: surface TLRs (2, 4, 5, 6) recognize typical bacterial
structures and therefore act via direct self-nonself discrimination. In contrast, TLR 3,
7, 8, 9 localize in intracellular lysosomal compartments and detect nucleic acids that
are not necessarily uniquely pathogen-associated structures. In this case, the
difference between self and nonself is detected only by the different localization of
host- and pathogen-derived nucleic acids, as host-derived nucleic acids normally do
not have access to the endosomal compartments 14,15 (Fig. 2).
51
Figure 2. Toll-like receptors. TLRs are a large family of pattern-recognition receptors that recognize conserved
molecular structures of microbial origin. TLRs localize either on the cell surface or in endosomal compartments.
Upon activation, most TLRs start signaling cascades via the common adaptor protein MyD88 with the exception of
TLR3 and TLR4 that can activate an alternative pathway. TLRs potently stimulate the innate immune system and
enable a cross-talk between the innate and the adaptive immune system, which is essential for induction of adaptive
immune responses. (Adapted from O’Neill51)
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The two signal model of naive B cell activation
According to the current two signal model, naïve B cell activation by T-
dependent antigens is induced by the sequential integration of two signals: Activation
is initiated by binding of the antigen to the BCR, which triggers a signaling cascade
leading to the upregulation of costimulatory molecules on the B cell surface. In
addition, stimulated BCRs mediate efficient antigen internalization allowing
processing and presentation of antigenic peptides on MHC class II molecules for
recognition by specific T cells 52,53. At the immunological synapse specific T cells are
activated and in turn stimulate B cells via CD40L-CD40 interaction and cytokines 54.
The current dogma is that the timely integration of BCR stimulation (signal one) and
T cell help (signal two) is both necessary and sufficient to drive naïve B cell
proliferation and differentiation to Ig secreting plasma cells 52 (Fig. 3).
Figure 3. The activation of naïve B cells. Crosslinking of B cell receptor by antigen delivers signal 1 and induces
upregulation of MHC II and costimulatory molecules on B cells. Specific T cells are activated at the
immunological synapse and stimulate B cells via CD40L and cytokines (signal 2). Timely integration of signal 1
and 2 induces naïve B cell activation, proliferation and differentiation.
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TLR costimulation as a mechanism for induction of B cell responses
It has been known for long time that mouse B cell responses are massively
increased when antigen is administered with pathogen-derived molecular structures as
LPS or in CFA containing bacterial components. It has been shown that mouse naïve
B cells can respond in vitro to LPS and CpG by undergoing extensive proliferation
and differentiation, even in the absence of BCR triggering or T cell help 55,56. Indeed
mouse B cells constitutively express a variety of TLRs, including TLR4 and TLR9,
which are triggered by LPS and CpG 57.
However, recent studies have revealed important differences in the expression
of TLRs between mouse and human B cells. Human B cells express TLR2, TLR6,
TLR7, TLR9 and TLR10 but not TLR4 and differ therefore in their spectrum of TLR
expression from mouse B cells, which do express TLR4 58,59 In addition, TLR
expression is differentially regulated in mouse and human B cells. While in mice both
naïve and memory B cells express TLRs, constitutive TLR expression is restricted in
humans to memory B cells. Human naïve B cells do not express TLR but are able to
upregulate TLRs following BCR stimulation 58. The coupling of BCR stimulation to
TLR expression endows the human system with a high degree of specificity since it
allows focusing of innate signals specifically on antigen stimulated and memory B
cells. The selective responsiveness of memory B cells to TLR agonists has been
suggested to be a mechanism to maintain serological memory by induction of
polyclonal memory B cell differentiation to plasma cells 60.
There is growing evidence that TLRs play an important role in induction of
mouse B cell responses. Recently it has been shown that particles containing proteins
and nucleic acids can induce autoantibody formation by synergistically engaging
BCR and TLR9 or TLR7 61-64. In addition, TLR signaling supports induction of T-
dependent B cells responses in mice 65. However, it remains to be established whether
and how TLR signals contribute to the activation of human naïve B cells.
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Aims of the study
In this thesis three aspects related to self-nonself discrimination were
addressed. In a first part it was determined whether Tregs are self-reactive. We have
established a sensitive assay for detection of TCR triggering that can be used for the
determination the TCR specificity of anergic T cell. Using this assay the frequency of
self-reactive TCRs present in the repertoire of mouse CD4+CD25+ regulatory T cells
and CD4+CD25- conventional T cells was quantified by measuring TCR triggering
upon stimulation with self-antigen bearing DCs (see manuscript 1).
Then we have addressed the question of how to define human Tregs in an
inflamed tissue using samples of patients suffering from the autoimmune disease
juvenile idiopathic arthritis (JIA). We have determined surface markers that allow
discriminating in the CD4+CD25+ compartment of an ongoing autoimmune response
Tregs from activated T cells. By use of this novel Treg marker the function of Tregs
in peripheral inflamed tissues was studied (see manuscript 2).
And finally, the impact of TLR-mediated context discrimination on the
induction of T-dependent B cell responses in the human system was studied. Using
improved methods for human naïve B cell isolation 66 and for induction of cognate
interactions between polyclonal human B and T cell populations we have analyzed
the effect of PAMPs in presence of BCR triggering and T cell help on activation,
proliferation, and differentiation of naïve human B cells (see manuscript 3).
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Manuscript 1: No evidence for self-reactivity of CD4+CD25+ T cells
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Abstract
Naturally-occurring regulatory T cells (Tregs) are able to suppress the
responses of normal naïve T cells in vitro and in vivo, and can prevent
experimentally-induced autoimmunity in vivo.  These properties suggest that Tregs
may function in the maintenance of self-tolerance in vivo, by specifically suppressing
the responses of autoreactive T cells.  This theory demands that Tregs should bear T
cell receptors (TCRs) largely specific for self-antigens.  Here we quantitatively
measure the frequency of self-reactive TCRs expressed by CD25+ Tregs, and by
CD25- naïve T cells.  We find that the self-reactivities of TCRs from both populations
are identical, and that neither contain strongly self-reactive TCRs.  This result is
difficult to reconcile with an antigen-specific role for Tregs in maintaining self-
tolerance.
                                                                                                                              Results
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Introduction
The immune system is able to respond to, and eliminate, organisms expressing
foreign antigens, and thereby provide protective immunity.  It must simultaneously
remain nonresponsive to potentially antigenic self-constituents, in order to avoid
autoimmunity. Understanding how this state of self-tolerance is achieved is one of the
fundamental goals of immunology.
The theory of clonal selection 67 proposed that lymphocytes bearing self-
reactive receptors should be deleted during their development. This was subsequently
shown to occur during the maturation of T lymphocytes in the thymus 68-70, and
represents the principal means by which self/non-self discrimination is established.
However, in spite of this, some T cells with receptors specific for self-antigens do
develop 71,72, and yet do not usually cause autoimmunity. There must therefore exist
additional ways in which self tolerance is maintained.
Naturally-occurring regulatory T cells (Tregs) have been proposed to fulfill
such a role 12. These cells are present as a subpopulation of 5-10% of CD4+ T
lymphocytes in normal individuals, and can be identified by their constitutive
expression of the IL-2 receptor a chain, CD25 73,74. They are able to suppress the
responses of other T cells, both in vitro 34-36,75 and in vivo 73,76,77. Moreover, CD25+
Tregs are able to prevent experimentally-induced autoimmunity in vivo: thymectomy
of mice 3 days after birth (at which time CD25+ Tregs have yet to appear in the
periphery), or transfer of naïve CD25- T cells from normal mice into lymphopenic
recipients (eg nude mice, or Rag- or CD3e-knockout mice), both lead to various
organ-specific autoimmune diseases 19,20,22,78,79. Reconstitution of such mice with
CD25+ T cells completely prevents disease.
Autoimmune diseases also occur in mice with genetic mutations which
prevent the development of regulatory T cells (eg scurfy, IL-2-knockout, and IL-2
receptor [IL-2R]-knockout mice), and can be prevented by transfer of CD25+ Tregs
into neonatal mice 24,80-83. These genetic models clearly suggest that CD25+ Tregs are
relevant in the physiological (as opposed to experimentally-induced) prevention of
autoimmunity, and lead to the question: are Tregs important throughout life,
specifically suppressing autoimmunity whilst allowing immune responses to foreign
organisms? This proposition implies that most Tregs should express TCRs specific for
self-antigens, if they are to avoid suppressing all immune responses 12,84.
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A number of studies have addressed the idea that TCR-specificity influences
the development of CD25+ Tregs:
 (i) CD25+ cells do not develop in TCR transgenic mice bred onto backgrounds which
prevent the expression of endogenous TCRs (eg Rag- or TCR-a-knockouts; 20,37,85-87,
implying that the specificity of the transgenic TCR is incompatible with Treg
development. In each case, Tregs are able to develop when endogenous TCRs can be
co-expressed.
(ii) CD25+ thymocytes are preferentially generated when some TCR transgenes are
expressed in mice also transgenically expressing their cognate antigen 37-39,77,88,89, or
after transplantation of thymi expressing the relevant antigen 73. However, the yield of
CD25+ thymocytes is very low in most cases, and in other cases (including the same
TCR transgenics crossed onto different antigen-expressing backgrounds) transgenic T
cells are deleted without generating CD25+ cells 37,89-91.
(iii) In wild-type mice, although CD25+ thymocytes appear to be resistant to deletion
by viral superantigens, they are susceptible to normal negative selection by self
peptide-MHC complexes 40,92-94.
These latter qualitative studies do not exclude, however, that there could be a
quantitative difference in the sensitivity of CD25+ & CD25- cells to negative selection
(as proposed by van Santen et al. 41). Thus, it remains possible, as suggested by
several TCR transgenic systems, that TCRs with an increased reactivity to self-
antigen could favour the thymic development or survival of CD25+ Tregs.
Despite the abundant research on their development, few reports have directly
addressed the self-specificity of the TCR repertoire of mature CD25+ Tregs. The
inherent difficulty of this stems from their anergic behaviour in vitro, which precludes
straightforward measurement of their responses to self-antigen bearing APCs. Both
Bensinger et al. 40 and Pacholczyk et al. 95 attempted to circumvent this problem by
providing exogenous IL-2, which is known to overcome the anergic behaviour of
Tregs in vitro 34-36. Neither group was able to detect substantial proliferation of CD25+
Tregs upon stimulation with autologous splenic APCs. The positive control in these
experiments was the proliferation of CD25+ Tregs derived from mice in which thymic
negative selection was completely absent – indicating that at least some self-reactive
TCRs must have been purged from the normal CD25+ Treg repertoire. However,
whether self-reactive cells remained, and to what extent, could not be determined.
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Hseih et al, 42 measured the ability of cloned TCR genes to augment the in vivo
expansion of naïve CD25- T cells in lymphopenic mice. They found that TCRs from
CD25+ Tregs conferred a greater proliferative advantage than did those from CD25- T
cells – suggesting an increased frequency of self-reactive TCRs. The absolute
frequency was not determined, however.
Here we describe the quantitative measurement of the frequencies of self-
reactive TCRs present in the repertoires of CD25+ Tregs, and of naïve CD25- T cells.
Results
Our experimental strategy was to generate T cell hybridomas by fusion of
CD25+ Tregs or naïve CD25- T cells with a TCR-negative thymoma. We could then
directly analyse the self-reactivity of hybridomas expressing TCR (the genes for
which must have been derived from the fused T cell populations), by stimulation with
autologous APCs.
To provide a direct and robust assay for TCR triggering, we used a reporter
gene in which green fluorescent protein (GFP) expression is driven by 9 tandem
copies of the NFAT (nuclear factor of activated T cells) binding motif derived from
the promoter of the human IL-2 gene 96; see figure 1a). TCR signaling in transduced
cells rapidly (≤20 mins, not shown) leads to NFAT-mediated transcription, and
expression of GFP. Importantly, the fraction of GFP-expressing cells is determined by
the strength of the TCR stimulus, allowing quantitative comparisons to be made of
TCR signaling 96; see figure 2a).
Following a similar approach to Sanderson & Shastri 97, we introduced the
reporter gene into a TCR a/b-negative derivative of the BW5147 thymoma 98, and
tested transduced clones for induction of GFP expression after activation with PMA +
ionomycin (figure 1b). All 40 clones tested showed activation-dependent GFP
expression (in the range 30-98% GFP+ cells, not shown), and 10 of these were further
screened by fusion with total mouse splenic T cells. Fusion efficiencies ranged from
10-3 to 10-4 (not shown), and 15-100% of the resulting hybridomas expressed GFP
upon stimulation with anti-CD3e antibodies (figure 1c). None of the parental
thymoma clones responded to anti-CD3e, as expected from their lack of TCR
expression. One thymoma clone was selected for use in subsequent experiments,
based on its high fusion efficiency and on the high frequency of hybridomas
generated with inducible GFP expression.
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To test the sensitivity of the system, we generated hybridomas from T cells
from DO11.10 mice, which carry a TCR transgene specific for a peptide derived from
chicken egg albumin (Ova; 99. DO11.10-derived hybridomas expressed GFP upon
stimulation by anti-CD3e antibodies, and by Ova-pulsed H-2d dendritic cells (DCs),
but did not respond to dendritic cells in the absence of Ova (figure 2a). The maximal
response was elicited by pre-pulsing DCs with >300mg/ml Ova protein, and induction
of GFP expression could still be detected by DCs pulsed with less than 500ng/ml
Ova. This range of sensitivity is comparable to that achieved by measuring
upregulation of CD69 expression on naïve, ex vivo DO11.10 CD4+ T cells (although
in this case the background in the absence of Ova is significantly higher; figure 2b).
We also examined whether the limit of detection would be appreciably increased if
DCs were pulsed with Ova, not alone, but as part of a complex mixture of many
proteins. We exposed DCs overnight to Ova protein, diluted into a soluble lysate
derived from multiple mouse tissues, with an absorbance at 280nm (A280) of >3 (thus
containing very approximately 2-3mg/ml protein). Induction of GFP expression by
DO11.10-derived hybridomas could still be measured with Ova concentrations of
<500ng/ml, although the fraction of GFP-expressing cells at higher concentrations
was significantly reduced (figure 2a). Hence, by extrapolating from these results using
DO11.10-derived hybridomas, the system can detect TCRs specific for proteins
present at ≥500ng/ml, or at approximately ≥0.025% in a complex mixture.
It was important to establish whether Tregs could generate hybridomas with
fusion efficiencies similar to those of naïve T cells. This would exclude the possibility
that hybridomas from CD25+ cells could be predominantly derived from a small sub-
population of contaminating non-Tregs. As a homogeneous source of Tregs, we used
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HA-TCR transgenic mice 100 crossed onto the Ig-HA transgenic background, in which
expression of the cognate antigen, influenza virus haemagglutinin (HA), is driven by
the immunoglobulin k promoter 101. In these mice all clonotype-expressing CD4+ T
cells behave as Tregs 38. Thus, expression of the clonotypic TCR serves as an
independent marker of Tregs and any contaminating CD25- cells in the sorted CD25+
population are unlikely to bias the results, since they function as Tregs, too. We sorted
clonotype-positive CD4+ CD25+ and CD25- Tregs from HA-TCR x Ig-HA double
transgenic mice, and naïve CD25- T cells from HA-TCR transgenic mice on a wild-
type genetic background, as controls. As expected, the naïve CD25- T cells, but not
the CD25+ and CD25- Tregs, proliferated in response to soluble anti-CD3e stimulation
in vitro (not shown). However, all sorted cell populations generated hybridomas with
comparable fusion efficiencies (within a two-fold range; figure 3a, left). In addition,
all hybridomas from sorted clonotype-expressing T cell populations continued to
express the clonotypic TCR (figure 3a, right), confirming the identities of the
originating T cells.
We also compared the antigen sensitivities of HA-TCR-expressing
hybridomas derived from Treg or naïve T cells. Both expressed GFP upon anti-CD3e
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stimulation, and had near-identical responses to H-2d DCs pulsed with the antigenic
HA peptide at all concentrations (figure 3b). Therefore, the nonresponsive character
of Tregs is completely lost in Treg-derived hybridomas. In addition, the hybridomas
showed clear responses (≈5-8% maximum response; figure 3c) to H-2d DCs pulsed
with a soluble tissue lysate (as described above) derived from Ig-HA transgenic mice,
further confirming that the system can detect T cell reactivity to self-antigens present
in the tissue lysate.
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We next generated hybridomas from CD4+ CD25+ Tregs, and from naïve CD4+ CD25-
T cells from the spleens of wild-type C57BL/6 mice. CD25- and CD25+ CD4+ cells
were sorted to ≥95% purity (figure 4a), and were assayed for their response to anti-
CD3e antibodies in vitro. In keeping with the published reports 34-36, CD25- cells
responded by proliferating vigorously, whereas CD25+ cells did not. Moreover,
CD25+ cells suppressed the proliferation of the CD25- cells in a cell dose-dependent
fashion (figure 4b). Therefore, the purified CD25+ T cells had the phenotypic and
functional characteristics of Tregs.
Prior to fusion, we stimulated both T cell populations with plastic-bound anti-
CD3e and anti-CD28 antibodies, in the presence of 100U/ml IL-2. These stimuli have
been previously described as sufficient to overcome the anergic state of CD25+ Tregs
34-36. Cells in both populations enlarged to form blasts and proliferated under these
conditions. By measuring the dilution of CFSE in identical, labeled cultures, we found
that the majority of input cells in both populations were induced to proliferate,
although CD25- cells underwent approximately one additional cell division compared
with CD25+ cells (figure 4c). Thus, there is no indication that any sub-population of
cells is able to preferentially expand in these cultures. In agreement with our previous
control experiments, CD25- and CD25+ cells generated hybridomas with similar
fusion efficiencies (figure 4d), further arguing that hybridomas from CD25+ cells are
not derived from a small number of contaminating, or otherwise abnormal, cells.
In three separate experiments, we generated and analyzed a total of more than
350 hybridomas derived from each of the CD25+ and CD25- cell populations. Upon
activation with anti-CD3e antibodies, >98% of hybridomas derived from both
populations expressed GFP, and the brightness of GFP-expressing cells was identical
(figure 4e). Hence, in accordance with our control experiments (figure 3b), TCR
signalling is not impaired in hybridomas derived from CD25+ Tregs. The fraction of
cells which could be induced to express GFP in each hybridoma varied from 17-98%
(median 71%, not shown), likely reflecting stochastic loss of the chromosomes
containing the NFAT-GFP reporter, TCR a or TCR b genes following fusion. In
subsequent analyses, therefore, we normalized the fraction of responding cells in each
hybridoma to the maximum response attainable using anti-CD3e stimulation.
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We measured the self-reactivity of the CD25+ Treg- and naïve CD25- T cell-derived
hybridomas by stimulating them using syngeneic DCs. The DCs were pulsed
overnight with a lysate of multiple mouse tissues, at A280>3, to provide them with a
source of tissue-spedific, as well as ubiquitously-expressed, self antigens. No
hybridomas from either population responded strongly (≥25% maximum response) to
this stimulation. The number of hybridomas responding at ≥1% maximum response
was ≈3-4%, and was not significantly different between CD25+ and CD25- cells
(figure 5a, right). By analysing a sufficient number of stimulated cells from each
hybridoma, we were able to detect induction of GFP expression above background
(which was less than 0.01% maximum response; see figure 2a) in ≈30% of
hybridomas from both groups; however, at no level of response did the fraction of
responding hybridomas differ between CD25+ and CD25- cells (figure 5a, left). Thus,
we find no evidence for self-reactivity of CD4+ CD25+ T cells.
To attain the maximum sensitivity of detecting tissue-specific self-antigens,
we further screened a reduced panel of 48 hybridomas derived from CD25+ cells
using DCs pulsed separately with each of the lysates from individual mouse tissues
(again, at a final A280>3). No hybridomas responded at a level higher than that seen
with the mixed lysate (not shown).
To ensure that our system could indeed detect self-reactive T cells, we
performed additional fusions using CD4+ T cells derived from AbEpIi- mice (‘single
peptide’ mice; 102. The I-Ab MHC class II molecules in these mice are all covalently
linked to a single, defined peptide. They are consequently unable to present peptides
derived from any other proteins, and thymic negative selection of self-peptide-specific
CD4+ T cells cannot occur. More than 40% of single peptide-derived hybridomas
responded strongly (≥25% maximum response) to stimulation by I-Ab wild-type DCs,
and 76% responded at ≥1% maximum response (figure 5b, right). Self-reactive T cells
are clearly easily detectable in this system. In contrast, upon stimulation by single
peptide-derived DCs, only ≈3% of the hybridomas responded at ≥1%, and their
response profile was almost identical to that of wild type CD4+ T cells responding to
wild type DCs (compare triangles in figure 5b to figure 5a).
We also wondered whether CD25+ and CD25- T cell populations might differ
in their level of alloreactivity. This might be expected if the TCRs of CD25+ Tregs did
not recognize specific self-peptides presented by MHC molecules, but had a higher
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affinity for the invariant backbones of the MHC molecules themselves. Although is
hard to imagine how such a scenario might help CD25+ Tregs to discriminate self-
from non-self-antigens, we nevertheless examined the anti-H-2d alloreactivity of the
hybridomas derived from CD25+ and CD25- cells from H-2b mice. The fraction of
hybridomas responding at ≥1% maximum response was ≈10%, significantly higher
than that responding to syngeneic APCs, but differed only slightly between CD25+
and CD25- cells (8% and 13%, respectively; figure 5c). We conclude that the
frequency of alloreactive TCRs is no higher amongst CD25+ Tregs than naïve CD25-
T cells. This result concurs with the studies of Dieckmann et al. 103, who found that
allo responses of Tregs were essentially normal, and of Pacholczyk et al. 95, who
found no evidence that TCRs used by CD25+ thymocytes bound preferentially to the
MHC framework.
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Discussion
Subject to a number of caveats (discussed below), our data indicate that
CD25+ Tregs are not self-specific, or at least that the frequency of strongly self-
specific cells in this population is sufficiently small to be undetectable amongst the
≈350 hybridomas analyzed here, and the frequency of weakly self-reactive cells is
identical to that of naïve CD25- T cells. Both scenarios are difficult to reconcile with a
role for CD25+ Tregs in suppressing autoimmunity in an antigen-specific fashion.
Experiments of this type are subject to a number of potential pitfalls: first,
CD25+ Tregs may be specific for rare, tissue-specific self-antigens, which were not
efficiently presented in our in vitro system, but which could nonetheless cause
autoimmunity in vivo without control by Tregs. Although we can never rule this
possibility out completely, we have quantified the limit of detection of our system
using hybridomas of known antigen-specificity (figure 2).  We were able to detect an
antigenic protein present in a mixture at less than ≈0.025%; thus, the self-antigens
recognized by Tregs, if there are any, should all be less abundant than this. While
tissue-specific antigens of such rarity certainly exist, many experimentally identified
autoimmune target-antigens are expressed at comparatively high levels (eg myelin
basic protein 104,105, insulin 106,107). So, the absence of CD25+ derived hybridomas
reacting to self-antigens in our system is not readily explainable by the universally
low expression of such antigens.
Second, CD25+ Tregs may recognize self-antigens with an affinity too low to
be discernable by our assay, but high enough to allow them to suppress unwanted
autoimmune responses. Indeed, the level of TCR stimulation required in vitro to elicit
suppression by Tregs is considerably lower than that needed for proliferation of naïve
CD25- T cells 34, and it has been proposed that the avidities of TCRs from CD25+
Tregs for self peptide-MHC complexes lie in a narrow range, above that required for
positive selection of CD25- T cells, but low enough to escape thymic negative
selection 12. We have attempted to tackle this issue by exploiting the very low
background and high sensitivity of the NFAT-GFP reporter construct. We were able
to detect TCR triggering above background in up to 30% of hybridomas in response
to self-antigens presented by DCs (figure 5a). The very low level responses of most of
these cells is probably well below that required for T cell activation in vivo. In fact,
we detected similar responses amongst single peptide-derived hybridomas to single
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peptide-derived DCs (figure 5b), corresponding to the recognition of the same
peptide-MHC complex responsible for positive selection in the thymus. However,
throughout the range of responses, the self-reactivity of CD25+ and CD25- T cells was
identical. Hence, if the TCRs from CD25+ Tregs do lie in a window of avidity for
self-antigens, it completely overlaps with the avidities of TCRs from naïve CD25- T
cells.
Third, as mentioned above, the frequency of self-reactive cells amongst
CD25+ Tregs may indeed exceed that amongst naïve CD25- T cells, yet still be so
small that such cells are absent from our analysis. Based on our failure to detect any
strongly self-reactive cells out of around 350 CD25+ derived hybridomas, such cells
must be present at a frequency of less than 1 in 116 (at a 95% confidence level), if at
all. If the role of Tregs in normal individuals is to specifically recognize, and suppress
autoimmunity against, self-antigens, this would imply that >99% of Tregs are in this
respect inert. Worse, they would share with naïve CD25- T cells an equal likelihood of
recognizing foreign, pathogen-derived antigens, when encountered for the first time.
Since an immune response in this instance is desirable, additional mechanisms would
be required to prevent Treg-mediated suppression. It is our opinion that this reductio
ad absurdium argues that even a low frequency of self-reactive Tregs is incompatible
with their role in antigen-specific prevention of autoimmunity.
The data presented here are seemingly at odds with those of Hsieh et al 42, who
concluded that a large proportion of Tregs recognize self-antigens. These authors
reintroduced cloned TCRs into naïve T cells (such that the recipient T cells now
expressed two TCRs: the endogenous [transgenic] TCR, and the newly-transduced
one), and used expansion after transfer into TCR-a-deficient mice as an indirect
measure of self-reactivity. Using random pools of ≈10,000 TCRs, they found that
those derived from CD25+ cells conferred a 2- to 4-fold greater expansion advantage
than did those from CD25- cells, and caused a wasting disease in the recipients.
Additionally, by selecting 10 over-represented CD25+ Treg-derived TCRs (the most-
reliably skewed to the Treg phenotype) from around 200 sequences, they identified 4
which individually bestowed an in vivo expansion advantage on transduced cells, and
one which also responded to autologous APCs in vitro. None of these individual
TCRs were described as conferring wasting disease. We feel that the apparent
discrepancy between these results and our own is simply in the interpretation. The
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expansion advantage imparted by the 10 selected CD25+ Treg-derived TCRs was
around 10-fold greater than by the random pool of 10,000. This reveals that the
selection criterion indeed enriched for the most-reactive TCRs; the lower bound for
the frequency of Treg-derived TCRs conferring an in vivo expansion advantage would
then be ≥1 in 51, and only 1 in 202 for TCRs, which lead to wasting disease. These
values are close to our own upper bound for the fraction of strongly self-reactive
Tregs (≤1 in 116, see above), using a different, more direct, assay. As we argued
above, we consider that such a scarcity of self-reactive CD25+ Tregs excludes that
self-specificity is important for their function.
Our finding that CD25+ Tregs generally do not bear TCRs specific for self-
antigens implies that self-recognition should not be required for their well-
documented suppression of experimentally-induced autoimmunity 19,20,22,78,79. In fact,
there are reports in which this has been shown to be the case. Both Hori et al. 75 and
Fontenot et al. 24 generated CD25+ Tregs by Foxp3-transduction of CD25- T cells.
These induced CD25+ cells therefore had identical (largely non self-specific) TCR
specificities to the CD25- cells from which they were derived. Nevertheless, these
cells were still able to suppress autoimmunity brought about by transfer of CD25-
cells into lymphopenic mice. In this situation, any preferential ability of Tregs to
discriminate self-antigens based on their TCR specificities would have been
completely abolished.
What, then, could be the mode of action of CD25+ Tregs in vivo? It is worth
noting that most experimental systems in which Tregs provide protection from
autoimmunity require the induction of a period of lymphopenia (eg by thymectomy,
or transfer of cells into lymphocyte-deficient recipients). A model consistent with
these studies is that Tregs act by preventing the dysregulated activation and/or
expansion of naïve T cells in such circumstances 108-111. Such a notion is supported by
experiments indicating that Tregs are able to limit the homeostatic expansion of
normal T cells during lymphopenia 82,112. Furthermore, Barthlott et al 111 found that
even TCR Tg non-Treg cells of irrelevant specificity could limit the expansion of
normal T cells in lymphopenic hosts, and prevented the development of autoimmune
disease.
At first glance, this hypothesis seems to be ruled out by the occurrence of
autoimmunity in mutant mice with a genetic block in the generation of CD25+ Tregs
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24,80-83. In these mice, disease arises during normal development, without requiring the
experimental induction of lymphopenia. However, Min et al, 113 have shown that the
normal neonatal environment supports lymphopenia-driven T cell proliferation and
expansion. It is conceivable that CD25+ Tregs are important at this period of life, non-
specifically restraining the proliferation and acvivation of naïve, potentially-
autoreactive T cells. In adults, in whom the peripheral lymphoid compartment is
‘full’, this suppression mechanism would not ordinarily be invoked. There are data
which support this idea: several groups have have depleted CD25+ cells in vivo in
adult mice using anti-CD25 antibodies, but this treatment did not result in
autoimmunity (114,115; the resulting depleted cells were able to confer autoimmunity
after transfer into lymphopenic recipient mice, indicating that Tregs had indeed been
functionally eliminated 110). In contrast, depletion of CD25+ cells in neonatal mice did
cause autoimmunity, with a similar rate of incidence as that following day 3
thymectomy 115,116.
We would like to stress that our finding that naturally occurring CD25+ Tregs
are largely not self-specific by no means precludes their potential therapeutic use, nor
does it argue that antigen-specific Tregs cannot be artificially generated for clinical or
other purposes. It does cast a doubt, though, on theories in which the physiological
role of Tregs is to suppress autoimmunity, but allow immunity, in an antigen-specific
fashion.
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Materials and Methods
Generation of NFAT-GFP transduced fusion partner cells. The minimal
human IL-2 promoter, containing three NFAT binding sites, was cloned by
polymerase chain reaction from the NFAT-LacZ plasmid (provided by N. Shastri),
and three copies were tandemly inserted upstream of the GFP coding sequence in a
self-inactivating retroviral vector (derived from pSir [Clontech]). Upon infection and
reverse transcription, the 5’ LTR of this vector is replaced by the mutant 3’ LTR in
which the enhancer elements (located at positions 198-298 in the MoMLV LTR) have
been deleted: thus, expression of GFP is driven only by the internal, NFAT-binding
site-containing promoter. Retrovirus-containing supernatant was collected following
transfection of Ecotropic Phoenix packaging cells (provided by G. Nolan), and used
to spin-infect a-b- BW5147 cells 98. Infected cells were cloned, and screened for
expression of GFP following activation using 100nM phorbol myristylate acetate
(PMA) + 1mg/ml ionomycin.
Hybridoma generation. Sorted splenic T cells were activated with plastic-
bound anti-CD3e (145.2C11) and anti-CD28 (37.51) antibodies in the presence of
100U/ml mouse IL-2 (produced in transfected X63 cells) for 2-3 days. Equal numbers
of activated T cells and the NFAT-GFP transduced fusion partner were then fused
using PEG-1500, and plated at limiting dilution in the presence of 100mM
hypoxanthine, 400nM aminopterin, and 16mM thymidine (HAT). Fusion efficiencies
represent the number of HAT-resistant clones generated per input activated T cell.
Isolation and assay of CD25+ Tregs. Splenic T cells were stained with anti-
CD4 (GK1.5) and anti-CD25 (PC61), and sorted into CD4+CD25- (naïve T cells) and
CD4+CD25+ (Tregs) populations. To assay in vitro suppressor activity, 20,000 naïve T
cells were CFSE-labeled, mixed with various numbers of Tregs, and stimulated for 4
days with 2000 immature DCs and 100ng/ml soluble anti-CD3e (145.2C11) in round-
bottomed wells. The number of dividing CD25- T cells (indicated by dilution of
CFSE) was determined by flow cytometry.
Activation using dendritic cells. DCs were generated from mouse bone
marrow cells by culture for 2 weeks in GM-CSF (produced in transfected X63 cells,
and used at 1/50 dilution of the supernatant; 117. One day before use, they were
activated by addition of 20ng/ml mouse TNF-a (R&D systems), or a soluble lysate
from mouse tissues (see below) at a final A280=3. Both treatments resulted in DC
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maturation, revealed by upregulation of MHC class II molecules (not shown). For
stimulating DO11.10-derived and HA-TCR transgenic-derived hybridomas, soluble
Ova or HA peptide (corresponding to amino acids 110-119 of influenza HA;
SFERFEIFPK) were added at the time of activation. To measure alloreactivity,
Balb/c-derived DCs (H-2d) were used to stimulate C57BL/6-derived hybridomas (H-
2b-restricted). Soluble lysates were produced from mouse brain, gut, heart, kidney,
liver, lung, lymph node, spleen and thymus by mechanical disruption in phosphate
buffered saline (PBS), followed by centrifugation to remove insoluble material, and
used either individually or mixed together at equal A280. Activated DCs were washed
and cultured overnight with an equal number of hybridomas or naïve CD4+ T cells.
The percentage of GFP-expressing hybridomas, or of CD69+ T cells (after staining
with the anti-CD69 antibody H1.2F3 [Pharmingen]) was determined by flow
cytometry.
Mice. C57BL/6, Balb/c, DO11.10 99, HA-TCR transgenic 100, Ig-HA x HA-
TCR double transgenic 38 and AbEpIi- (‘single peptide’ mice; 102 mice were
maintained under SPF conditions, and used at 8-12 weeks of age. DO11.10, HA-TCR
transgenic and Ig-HA x HA-TCR double transgenic mice were on an inbred Balb/c
background; single peptide mice were on an outbred C57BL/6 x 129/Sv background,
with an H-2b MHC haplotype. All experiments were performed with the approval of
the Swiss Veterinary office.
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Abstract
A better understanding of the role of CD4+CD25+ regulatory T cells in disease
pathogenesis should follow from the discovery of reliable markers capable of
discriminating regulatory from activated T cells. We report that the CD4+CD25+
population in synovial fluid of juvenile idiopathic arthritis (JIA) patients comprises
both regulatory and effector T cells that can be distinguished by expression of CD27.
CD4+CD25+CD27+ cells expressed high amounts of Foxp3 (43 % of them being
FoxP3+), did not produce IL-2, IFN-γ or TNF, and suppressed T cell proliferation in
vitro being, on a per cell basis, 4-fold more potent than the corresponding peripheral
blood population. In contrast, CD4+CD25+CD27− cells expressed low amounts of
Foxp3, produced effector cytokines and did not suppress T cell proliferation.
Following in vitro activation and expansion regulatory but not conventional T cells
maintained high expression of CD27. IL-7 and IL-15 were found to be present in
synovial fluid of JIA patients and when added in vitro abrogated the suppressive
activity of regulatory T cells. Taken together these results demonstrate that, when
used in conjunction with CD25, CD27 is a useful marker to distinguish regulatory
from effector T cells in inflamed tissues and suggest that at these sites IL-7 and IL-15
may interfere with regulatory T cell function.
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Introduction
There is now clear evidence that a distinct population of naturally occurring
regulatory T cells, which can be identified by the constitutive expression of CD4 and
CD25, plays an essential role in controlling autoimmunity 12. Regulatory T cells are
generated in the thymus or in periphery 20,118 and, once activated, suppress other T
cells by an as yet uncharacterized contact-dependent, cytokine-independent
mechanism 35. A functional result of suppression is impaired production of IL-2 35 ,
although evidence has been provided that an initial IL-2 production by responder cells
is necessary for expansion of CD4+CD25+ T cells and induction of their suppressor
function 119. The suppressor function of regulatory T cells can be relieved by
exogenous IL-2 that acts on both regulatory and responder T cells and by IL-6 that
blocks suppression at the level of responder cells 18,34.
The development and function of regulatory T cells is critically dependent on
the transcriptional repressor Foxp3 24,75,120. Mice and humans that lack Foxp3 die
from severe autoimmune diseases 80,121-123, while transduction of Foxp3 in naïve CD4+
T cells is sufficient to convert these cells into regulatory T cells 24,75. Since Foxp3 is
the master control gene, it is in principle the most specific marker for regulatory T
cells. However, the facts that Foxp3 is expressed exclusively intracellularly and that
reliable reagents for staining are not yet available prevent its use for the identification
and isolation of regulatory T cells.
CD25 is the hallmark antigen of regulatory T cells in mice and humans 19,103,124-
126. In normal conditions, CD25 appears to identify a relatively homogeneous
population of anergic regulatory T cells, although some heterogeneity may exist. For
instance it has been reported that among CD4+CD25+ T cells those expressing CD103
or CD62L are more suppressive than their negative counterparts 127-129. Other useful
markers of regulatory T cells under normal conditions include GITR, CTLA-4 and, in
mice, neuropilin-1130-132.
There is growing interest in the identification of regulatory T cells in various
pathological conditions and recent studies indicate that CD4+CD25+ cells with
regulatory function can be indeed detected in inflamed tissues 43-45. However, the
identification of regulatory T cells in an ongoing immune response or in inflamed
tissues in complicated by the fact that all the above markers, including CD25, are also
expressed on activated T cells 133. A possible heterogeneity of the CD4+CD25+ subset
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in inflamed tissues has not been addressed so far and the problem therefore remains
how to discriminate in an ongoing immune response regulatory from activated
effector T cells.
Here we report that CD27 is stably expressed on regulatory T cells and can be
used in conjunction with CD25 expression to discriminate in inflamed synovia
regulatory T cells, expressing high amounts of Foxp3 and endowed with potent
suppressive activity, from Foxp3− effector T cells devoid of suppressor activity. We
also show that Il-7 and IL-15 are present in synovial fluid and in vitro abrogate the
suppressive function of regulatory T cells.
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Results
CD4+CD25+ T cells from synovial fluid of JIA patients express high amounts of
Foxp3 and show suppressor activity in vitro.
Mononuclear cells were isolated from both synovial fluid and peripheral blood
of 15 JIA patients (7 with polyarticular and 8 with oligoarticular disease course) and
analyzed for the expression of CD4 and CD25 (Fig. 1A,B). The percentage of CD25+
cells within the CD4+ population ranged from 4 to 11.6 (median, 8.6) in peripheral
blood, a value comparable to that found in healthy donors (not shown), while in
synovial fluid it was significantly higher ranging from 6.5 to 35.2 (median, 12.3) (Fig.
1B).
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Figure 1. CD4+CD25+ T cells are enriched in synovial fluid of JIA patients, express high amounts of
Foxp3 mRNA and efficiently suppress proliferation of CD4+CD25− autologous T cells. A) PBMC and
SFMC from the same JIA patient were stained for CD4 and CD25. B) Percentages of CD4+CD25+ in PBMC
and SFMC in 15 JIA patients. P value determined by Wilcoxon rank test. C) PBMC and SFMC were sorted
based on expression of CD4 and CD25, and analyzed for expression of Foxp3 mRNA relative to 18S rRNA by
quantitative real time PCR. One representative experiment out of 10. D) Proliferation of 1.5 x 104 CFSE-labeled
PB CD4+CD25− T cells stimulated by anti-CD3 and DCs in the presence of equal numbers of autologous
CD4+CD25− T cells (open histograms) or CD4+CD25+ T cells (filled histograms) isolated from PBMC or
SFMC. The total number of responder T cells that had performed one or more cell divisions was determined by
CFSE dilution analysis. The percentage of suppression was calculated from the number of dividing responder
cells in presence of CD4+CD25+ T cells as compared to their number in presence of CD4+CD25- control cells.
One representative experiments out of 5.
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CD4+CD25+ and CD4+CD25− T cells were isolated from PB and SF of the
same JIA patient and analyzed for expression of the transcription factor Foxp3 using
quantitative real-time PCR. Foxp3 mRNA was higher in CD4+CD25+ as compared to
CD4+CD25− cells in both PB and SF (Fig. 1C). However, the amount of Foxp3
mRNA was much higher in the two populations isolated from SF than in those
isolated from PB (Fig. 1C). These findings suggest that synovial CD4+CD25+ T cells
may be activated in vivo and that some regulatory T cells may be present within the
CD4+CD25− subset. Indeed, upon in vitro stimulation PB CD4+CD25+ regulatory T
cells, and to a lower extent CD4+CD25− T cells 134, rapidly upregulated Foxp3 mRNA
(Supplementary Fig. 1).
To examine the suppressive activity in vitro, SF and PB CD4+CD25+ T cells
were added at a 1 to 1 ratio to cultures of CFSE-labeled autologous PB CD4+CD25−
responder T cells stimulated by DCs and anti-CD3. As control, responder T cells were
cultured in presence of unlabeled CD4+CD25− T cells. Four days later cultures were
analyzed by FACS and the total number of responder T cells that had performed more
than one cell division was determined by CFSE dilution analysis. The percentage of
suppression was calculated from the number of dividing responder cells in presence
of CD4+CD25+ T cells compared to their number in presence of CD4+CD25- control
cells. As shown in Fig. 1D, CD4+CD25+ T cells isolated from PB or SF potently
suppressed T cell proliferation (93% and 98.3% inhibition, respectively). We
conclude that synovial fluid contains a large population of CD4+CD25+ T cells
characterized by high expression of FoxP3 and suppressor activity in vitro.
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Supplementary Figure S1. Transient upregulation of Foxp3 mRNA in CD4+CD25+ and CD4+CD25− cells
upon TCR stimulation. A) CD4+CD25+ T cells were sorted from peripheral blood and stimulated by plate-
bound CD3 (filled squares) or CD3 plus CD28 antibodies (filled circles). B) CD4+CD25+ regulatory T cells
(filled squares), CD4+CD45RO+  memory T cells (open squares) and CD4+CD45RO− naïve T cells (open
diamonds) were stimulated by plate-bound CD3 antibodies. Foxp3 mRNA was determined at the time
indicated by real-time PCR and normalized to the amount of 18S rRNA in each sample.
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CD27 discriminates between regulatory and activated T cells in synovial fluid.
Since CD25 is an activation marker, the pool of CD4+CD25+ cells in SF may
contain not only regulatory T cells but also activated T cells. To dissect a possible
heterogeneity, we separated SF CD4+CD25+ T cells according to the expression of
several cell surface markers and used Foxp3 mRNA to monitor the presence of
regulatory T cells. Subsets defined by presence or absence of CTLA-4, CD62L, CD69
and GITR contained comparable amounts of Foxp3 mRNA (Fig. 2A). Similar data
were obtained using CCR4, VLA-4 and CD103 (data not shown). Thus, these
markers, known to be expressed on circulating regulatory T cells 103,124-126,135-137, did not
segregate with FoxP3 expression in cells of inflamed synovia.
CD27 is a TNFR-family member that is expressed on naïve and subsets of
memory T cells and is lost on terminally differentiated effector T cells 138,139. Since the
latter are highly enriched in SF of adult rheumatoid arthritis and JIA patients 140,141, we
asked whether CD27 may discriminate regulatory from activated effector T cells in
inflamed joints. Indeed, in some synovial samples we noted that a high proportion (up
to 50%) of CD4+CD25+ T cells were CD27− (Fig. 2B and Table II).
CD4+CD25+CD27− cells were also found in PB of patients and healthy adults although
at lower frequency (mean 15.6%, range 8.3-33 in 14 patients and 7.9%, range 2.6-
11.3 in 5 controls).
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Figure 2. CD27 identifies Foxp3 expressing cells within CD25+ and CD25− synovial CD4+ T cells. A)
CD4+CD25+ SFMC were stained with antibodies to CTLA-4, CD62L, CD69 and GITR. Positive and negative
subsets were sorted and analyzed for Foxp3 mRNA. Mean±SD of three separate experiments. B) PBMC and
SFMC from patient 12 were stained with antibodies to CD4, CD25 and CD27. The histograms show the
expression of CD27 on gated CD4+CD25− or CD4+CD25+ T cells. C) SFMC were sorted according to the
expression of CD4, CD25 and CD27, and analyzed for expression of Foxp3 mRNA. For comparison the value
in CD25+CD27+ was set to 100. Mean±SD of 3 separate experiments.
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The four subsets of CD4+ cells identified according to the expression of CD25
and CD27 were isolated from SF and PB of JIA patients and from PB of adult healthy
donors and tested for Foxp3 mRNA expression. FoxP3 mRNA was at least 10 fold
higher in CD4+CD25+CD27+ cells as compared to CD4+CD25+CD27− cells (Fig. 2C
and Supplementary Fig. 2). Low amounts of Foxp3 mRNA were also found in
CD4+CD25−CD27+ T cells, and no Foxp3 was detected in CD4+CD25−CD27− cells.
To estimate the frequency of Foxp3 expressing SF T cells within the four
subsets we used a sensitive PCR method to detect Foxp3 in replicate samples
containing limiting numbers of T cells (5 cells per sample). The highest frequency of
FoxP3+  cells (41.6%) was found in the CD4+CD25+CD27+ subset, while the
CD4+CD25+CD27− and the CD4+CD25−CD27+ subsets showed much lower
frequencies (6.2% and 2.7%, respectively) and the CD4+CD25−CD27− subset was
negative (Fig. 3). Considering that frequencies are underestimated, these results
suggest that CD27 marks a homogeneous population of Foxp3 expressing cells in
inflamed synovia.
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Supplementary Figure S2. CD27 identifies Foxp3 expressing cells within peripheral blood CD4+CD25+
cells from JIA patients and adult healthy donors. PBMC from two JIA patients (A) and 4 adult healthy
donors (B) were sorted according to the expression of CD4, CD25 and CD27 and analyzed for expression of
Foxp3 mRNA. For comparison the value in CD25+CD27+ was set to 100. Values represent mean ± SD.
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Figure 3. Foxp3 mRNA in
CD4+CD25+ T cell subsets in
samples containing limiting cell
numbers.  CD4+ T cell subsets were
sorted according to the expression of
CD25 and CD27 and then re-sorted
collecting 16 replicates of 5 cells
each that were subsequently analyzed
for expression of Foxp3 by PCR.
Amplification of CD3 was used as
control.
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GITR and CTLA-4 were expressed at comparable levels on
CD4+CD25+CD27+  and CD4+CD25+CD27− cells, whereas CD62L and CCR4 were
expressed on a higher proportion of CD27+ cells (Supplementary Fig. S3).
In addition, upon TCR triggering CD4+CD25+CD27+ T cells did not express
IL-2, TNF or IFN-γ  mRNAs whereas CD4+CD25+CD27− cells expressed high
amounts of cytokine mRNAs (Supplementary Fig. S4). Taken together these findings
are consistent with the notion that CD4+CD25+CD27+ cells are regulatory cells while
CD4+CD25+CD27− represent activated effector cells.
To directly test the suppressive function, the four subsets identified by the
expression of CD25 and CD27 were isolated by cell sorting from synovial fluid and
added to cultures of CFSE-labeled PB CD4+CD25- T cells. As shown in Fig. 4A,
suppressive activity was restricted to the CD4+CD25+CD27+ subset. The other 3
subsets either did not interfere or even enhanced T cell proliferation (Fig. 4A).
synovial fluid CD4+CD25+CD27+ T cells were, on a per cell basis, 4-fold more potent
as compared to CD4+CD25+CD27+ T cells isolated from peripheral blood of the same
patient (Fig. 4B). We conclude that based on four different criteria (expression of
FoxP3 mRNA, expression of surface markers, lack of cytokine production and
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Supplementary Figure S4. Cytokine mRNA by synovial fluid CD4+ T cell subsets isolated according to the
expression of CD25 and CD27. Cells were isolated by cell sorting and stimulated by CD3 antibodies and PMA.
Cytokine mRNAs were measured after 6 hours by real-time PCR.
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Supplementary Figure S3. Expression of
GITR, CTLA-4, CD62L and CCR4 on
CD4+CD25+CD27+ and CD4+CD25+CD27−
T cells. CD4+CD25+ synovial T cells were
stained with antibodies to CD27, GITR,
CTLA-4, CD62L, and CCR4. Shown is the
percentage of marker positive cells within
CD27+ and CD27− subsets (Mean±SD of
seven patients).
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suppression of T cell proliferation) CD27 expression in the context of CD25
expression allows discrimination of regulatory from activated/effector T cells in
inflamed joints.
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Figure 4. CD27 identifies potent suppressor cells within CD4+CD25+ synovial T cells. A) Proliferation of
CFSE-labeled CD4+CD25− peripheral blood T cells stimulated by anti-CD3 and DCs in the absence (open
histogram) or presence (filled histogram) of equal numbers of the indicated autologous CD4+ T cells isolated
from synovial fluid. The percentage inhibition was calculated as in Fig. 1. Comparable results were obtained
using synovial T cells isolated from patients #14 (shown) and #2, 5 and 7. B) Proliferation of CFSE-labeled
CD4+CD25− peripheral blood T cells in the presence of serial two-fold dilutions of autologous CD4+CD25+CD27+
T cells from peripheral blood (open circle) or synovial fluid (filled square). Shown is the total number of
responder T cells that had undergone more than one cell division. Mean±SD of triplicate cultures. Comparable
results were obtained with samples from patients #15 (shown) and #5 and 7.
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CD27 is retained on regulatory T cells following activation and expansion.
It is known that CD27 is lost upon terminal differentiation of conventional
CD4+ T cells 138. To investigate whether regulatory T cells may lose or retain CD27
expression upon activation, we isolated CD4+CD25+CD27+ regulatory T cells and
CD4+CD25−CD27+ naïve and memory T cells from PB (Fig. 5A). Cells were labeled
with CFSE and stimulated with anti-CD3 in the absence or presence of exogenous IL-
2 or anti-CD28. As shown in Figure 5B and C, CD4+CD25− T cells proliferated
extensively and downregulated CD27 expression as a function of cell division. In
contrast, CD4+CD25+ regulatory T cells proliferated poorly in the absence of IL-2
whereas they performed several cell divisions when exogenous IL-2 or costimulation
was provided. Remarkably, in both conditions proliferating regulatory T cells retained
high expression of CD27. We conclude that CD27 is a stable marker of regulatory T
cells that is retained following activation and expansion.
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Figure 5. CD27 is stably expressed in proliferating regulatory T cells whereas it is downregulated on
activated non-regulatory T cells. A) CD4+CD25+CD27+ regulatory T cells and CD4+CD25−CD27+ T cells
(comprising naïve and memory cells) were sorted from peripheral blood to >99% purity. B) Cells were labeled
with CFSE and stimulated with plastic-bound CD3 antibodies in the absence or presence of IL-2 or CD28
antibodies. CD27 expression was measured as a function of cell division on day 5 (left panel) and day 10 (right
panel). One representative experiment out of three performed.
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Different proportions of CD4+CD25+ subsets in JIA patients with polyarticular
or oligoarticular disease.
Some of the patients in this study had the disease limited to a few joints
(persistent oligoarticular), whereas others showed a more aggressive polyarticular
involvement (extended oligoarticular, polyarticular and systemic) (Table I and II).
While the percentage of total CD4+CD25+ cells did not differ significantly between
the two groups, the relative proportion of CD27+ and CD27− cells within the
CD4+CD25+ subset in affected joints was significantly different (Fig. 6A). Patients
with polyarticular disease showed higher proportion of CD27− activated/effector cells
and slightly lower proportion of CD27+ regulatory T cells as compared to patients
with oligoarticular disease that showed a significantly higher ratio of regulatory to
activated cells (Fig. 6B).
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Figure 6. Differential distribution of CD25+CD27+ regulatory and CD25+CD27− activated/effector cells
within synovial CD4+ T cells of JIA patients with oligoarticular or polyarticular disease course. A)
Percentages of total CD4+CD25+ T cells and CD27+ and CD27− subsets in 13 JIA patients with oligoarticular
disease course (white bars) and 12 JIA patients with polyarticular disease course (grey bars). B) Ratio between
regulatory and activated/effector cells in oligoarticular (white bars) or polyarticular (grey bars) JIA patients.
Boxes contain values falling between the 25th and 75th percentiles. Wiskard lines that extend from the boxes
represent the highest and the lowest values from each subgroup. The lines in the boxes represent median values.
P value determined by Mann Whitney U test. See also Table II for data from individual patients.
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IL-7 and IL-15 are present in synovial fluid and limit the suppressor activity of
regulatory T cells.
Biopsies of synovial tissues were obtained from 3 JIA patients. When
analyzed by immunohistochemistry, regulatory T cells co-expressing CD4, CD25 and
CD27 were found in lymphoid aggregates (Fig. 7).
To investigate the possibility that cytokines that are present in the inflamed
tissue may interfere with regulatory T cell function, we tested a large panel of
recombinant cytokines for their capacity to block the suppressive activity of
regulatory T cells in vitro. The activity of regulatory T cells was strongly reduced in
the presence of IL-2, IL-7 and IL-15 and virtually abolished when IL-7 and IL-15
were added together (Fig. 8A). In contrast, the pro-inflammatory cytokines IL-6, IL-
12, TNF and IFN-γ, as well as another γ-common dependent cytokine, IL-4, were
ineffective while TGF-β and IL-10 showed direct suppressive activity even in the
absence of regulatory T cells (Fig. 8A). Remarkably, IL-7 and IL-15 were detected in
the synovial fluid of JIA patients, IL-7 being significantly higher in patients with
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Figure 7. Distribution of CD4+CD25+CD27+ regulatory T cells in lymph nodes and synovial tissues. A-C)
Serial sections of a reactive lymph node stained with antibodies to CD4 (A) CD25 (B) and CD27 (C). D-H) Serial
sections of synovial biopsy from a JIA patient showing a T and B lymphoid aggregate stained with antibodies to
CD3 (D) CD20 (E) CD27 (F) CD25 (G) CD4 (H). Panel I shows a consecutive section stained with CD25 (red)
and CD27 (green) by two color fluorescence.
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polyarticular as compared to patients with oligoarticular disease (Fig. 8B). Taken
together these results suggest that in inflamed tissues IL-7 and Il-15 may substantially
limit the suppressor function of regulatory T cells.
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Figure 8. IL-7 and IL-15 counteract the suppressor activity of regulatory T cells and are present in
synovial fluid of JIA patients. A) Proliferation of CFSE-labeled CD4+CD25− peripheral blood T cells
stimulated by TSST-pulsed DCs in the absence (open histograms) or presence (filled histograms) of equal
numbers of the CD4+CD25+ T cells. The cultures were set up in medium alone (no cytokines) or in medium
supplemented with the indicated cytokines. B) IL-7 and IL-15 were quantified by ELISA in sera and synovial
fluid from 15 oligoarticular (white bars) and 15 polyarticular (grey bars) JIA patients and in sera from 12 age-
matched healthy controls (black bars). Boxes contain values falling between the 25th and 75th percentiles.
Wiskard lines that extend from the boxes represent the highest and the lowest values from each subgroup. The
lines in the boxes represent median values. P value determined by Mann Whitney U test.
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Table I. Clinical characteristics of JIA patients included in the study
RF: rheumatoid factor; SF: synovial fluid; ESR: erythrocyte sedimentation rate; NSAID:
non steroidal anti-inflammatory drugs; MTX: methotrexate; CS: corticosteroids, CyA:
Cyclosporin A.
Patient Sex JIA form Age
Disease
duration
n. active
joints ESR Treatment
1 F Polyarticular  RF- 6,2 3,5 25 20 MTX, CyA
2 F Extended oligoarticular 2,8 0,9 20 36 NSAID
3 F Extended oligoarticular 9,5 7,1 2 96 MTX
4 F Polyarticular  RF- 5,4 0,8 27 53 NSAID
5 F Extended oligoarticular 10,4 9,3 7 34 MTX
6 M Systemic 4,3 1,7 4 97 MTX, CS
7 F Extended oligoarticular 5,1 3,2 3 25 MTX
8 F Extended oligoarticular 6,9 5,0 2 24 MTX
9 F Polyarticular  RF- 5,2 1,9 8 20 MTX, NSAID
10 F Extended oligoarticular 6,3 5,2 6 60 MTX
11 F Polyarticular  RF- 9,9 8,5 3 34 CyA, NSAID
12 F Systemic 10,3 0,8 16 96 MTX, NSAID
13 F Persistent oligoarticular 8,5 7,1 4 12 -
14 M Persistent oligoarticular 4,2 2,1 1 11 NSAID
15 F Persistent oligoarticular 12,9 4,7 1 11 NSAID
16 F Persistent oligoarticular 4,0 1,3 2 13 NSAID
17 F Persistent oligoarticular 2,5 1,1 1 11 NSAID
18 F Persistent oligoarticular 9,3 6,2 3 14 NSAID
19 F Persistent oligoarticular 2,9 1,6 2 25 -
20 F Persistent oligoarticular 11,9 3,1 1 26 NSAID
21 F Persistent oligoarticular 6,0 1,6 2 36 -
22 F Persistent oligoarticular 3,6 1,9 2 14 NSAID
23 F Persistent oligoarticular 6,7 5,8 1 18 NSAID
24 F Persistent oligoarticular 8,1 3,6 2 26 NSAID
25 M Persistent oligoarticular 14,2 9,3 1 12 NSAID
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Table II. Distribution of CD27 in synovial CD4+CD25+ and CD4+CD25− T cells subsets in
JIA patients with oligoarticular and polyarticular disease course.
a) Percentages of total CD4+ synovial fluid (SF) T cells;
b) Percentage of CD27− cells within CD4+CD25+ cells;
c) Percentage of CD27− cells within CD4+CD25− cells.
SF CD4+CD25+ SF CD4+CD25−
Patient Disease course CD27+ CD27− %CD27− CD27+ CD27− %CD27−
1 Polyarticular 16,8a 9,7a 36.5b 48a 24,9a 34.1c
2 Polyarticular 6,8 4,3 38.7 42,7 46,2 52.0
3 Polyarticular 11,2 5,8 34.1 23,3 59,7 41.1
4 Polyarticular 6,3 3,4 35.1 43 47,6 52.5
5 Polyarticular 8,7 4,2 32.6 42 45 51.7
6 Polyarticular 8,1 5,6 40.9 57,2 29,0 33.6
7 Polyarticular 7,5 1,4 15.7 39,7 51,4 56.4
8 Polyarticular 5,3 1,2 18.4 76 17,3 18.5
9 Polyarticular 32,3 2,9 8.2 19,7 43 68.5
10 Polyarticular 8,3 2,4 22.4 27,7 61 68.8
11 Polyarticular 10,5 2,2 17.3 68,2 19 27.0
12 Polyarticular 7,7 8,4 52.2 39 44,2 53.1
13 Oligoarticular 9,1 2,7 22.9 32 55 63.2
14 Oligoarticular 10,7 1 8.5 85 4,9 5.4
15 Oligoarticular 16 1,2 7.0 73 8 9.9
16 Oligoarticular 33 1,2 3.5 54 11,5 17.5
17 Oligoarticular 6,8 3 30.6 36 54 60.0
18 Oligoarticular 7,3 3,6 33.0 50 38 43.2
19 Oligoarticular 16,9 1,5 8.1 56 25 30.9
20 Oligoarticular 9,9 1,2 10.8 68,8 20 22.5
21 Oligoarticular 9,0 1,7 15.9 55 34 43.0
22 Oligoarticular 10,2 1,8 15.0 56 31 35.6
23 Oligoarticular 11,0 0,5 4.3 71 17 19.3
24 Oligoarticular 7,6 1,1 12.6 62 28 31.1
25 Oligoarticular 13,6 1,07 11.1 63 28 30.8
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Discussion
In this study we addressed the problem of identifying naturally occurring
regulatory T cells in inflamed tissues. We found that in synovial fluid of JIA patients
CD27 expression can be used to discriminate, within the CD4+CD25+ subset,
regulatory T cells from activated effector T cells. CD27 is expressed on regulatory T
cells in both peripheral blood and synovial tissues and is retained by these cells
following activation and clonal expansion in vitro whereas CD27 is absent on effector
T cells and is rapidly lost on CD27+ naïve and memory T cells following activation
142,143. Thus, although CD27 is not a specific marker for regulatory T cells, the
differential regulation of expression in regulatory and conventional T cells makes it a
suitable marker for the identification of regulatory T cells in inflamed tissues.
The intensity of CD25 expression is considered a reliable marker for
regulatory T cells in peripheral blood (16). However, this may not be sufficient to
identify regulatory T cells in inflamed tissues. Indeed a recent study demonstrated that
CD25dim cells from synovial fluid express Foxp3 and have suppressive activity 46. In
this regard, we found that CD27 is expressed not only on all CD25bright cells, but also
of a sizeable proportion of CD25dim cells and that CD25dimCD27+ and
CD25brightCD27+ T cells express comparable amounts of Foxp3 mRNA (C.R.R.,
unpublished data). We conclude that the combination of CD25 and CD27 allows
identification of most of regulatory T cells while effectively excluding effector T
cells.
Growing evidence over the past few years indicates that CD27, as well as
other members of the TNFR family, such as OX40 (CD134) and 4-1BB (CD137),
plays an important role for the effective generation of many types of T cell responses
144. It remains to be established what role CD27 may play in regulatory T cell function
and whether sustained expression of CD27 on regulatory T cells contribute to their
maintenance in vivo.
Using limiting dilution analysis we could estimate that 41% of
CD4+CD25+CD27+ T cells isolated from inflamed joints express Foxp3. The
possibility of isolating a rather homogeneous population of regulatory T cells from
inflamed tissues was instrumental to establish their relative potency as compared to
regulatory T cells from peripheral blood. A direct comparison of regulatory T cells
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from synovial fluid and peripheral blood of the same patient revealed that synovial
regulatory T cells expressed much higher levels of Foxp3 and were on a per cell basis
4-fold more potent in suppressing T cell proliferation than peripheral blood regulatory
T cells. As activation by anti-CD3 and IL-2 increases both Foxp3 expression and
suppressor function of peripheral blood regulatory T cells 50, these findings suggest
that the increase potency of synovial regulatory T cells is a consequence of their
activated state in vivo.
The relevance of discriminating regulatory from effector T cells in inflamed
tissues is underlined by our finding that in the joints of JIA patients up to 50% of
CD4+CD25+ T cells were CD27− effector T cells and that the ratio of regulatory to
activated T cells was higher in patients with oligoarticular disease course than in those
with severe polyarticular disease course. Since the contamination of effector T cells
can be substantial and varies with disease state it will be important to reassess the
presence of regulatory T cells in other pathological tissues 43,45.
Although regulatory T cells can be found in tissues undergoing chronic
inflammation it remains to be established whether they exert their function in vivo.
Besides possible intrinsic defects in regulatory T cells 47-49, there may be several
mechanisms that limit the efficacy of regulatory T cells in peripheral inflamed tissues.
For instance, in vitro preactivated T cells become resistant to suppression and this
resistance is dependent on the strength and duration of the stimulus 45,50. We also
found that naïve T cells become completely refractory to suppression 24 hours after
TCR stimulation (C.R.R., unpublished). In addition, exogenous signals such as those
provided by GITR-L and IL-6 render responsive T cells resistant to suppression
mediated by CD4+CD25+ regulatory T cells 18,145. We screened a large panel of
cytokines for their capacity to relieve suppression in vitro and found that IL-7 and IL-
15, and more effectively a combination of the two, can counteract the suppressor
function of regulatory T cells. Based on these results and on the finding that both IL-7
and IL-15 can be detected in the joint fluid of JIA patients, we suggest that in target
tissues the function of regulatory T cells may be substantially limited by these
cytokines and that therapies that aim at neutralizing such cytokines may not only
decrease bystander T cell activation but also reconstitute the suppressor function of
regulatory T cells.
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Materials and methods
Patients. Twenty-five consecutive JIA patients diagnosed according to ILAR
Durban’s criteria 146 were included in the study. All patients had active disease and
underwent synovial fluid aspiration for steroids injection. To be included in the study,
patients with persistent oligoarticular course should have presented a disease duration
longer that 1 year. In all cases, a steroid injection in the same joint in the previous 6
months was considered as an exclusion criterion.  The patients tested in the functional
studies were under NSAID and/or methotrexate treatment. The main clinical and
laboratory features and the ongoing treatment at the moment of the study are reported
on Table I. Approval for the study was obtained from the institutional medical ethics
review board.
Media and reagents. The medium used throughout the experiments was RPMI
1640 supplemented with 10% fetal calf serum, 1% Glutamax, 1% nonessential amino
acids, 1% pyruvate, 50 U/ml penicillin, 50 µg/ml streptomycin (all Invitrogen), 5x10-5
M 2-mercaptoethanol (Merck). Recombinant human IL-6, IL-7, IL-10, IL-12, IL-15,
IFN-γ, TNF, and TGF-β were purchased from Pharmingen. IL-2 and IL-4 were
produced in our laboratory using the myeloma-based expression system.
FACS analysis. The following monoclonal antibodies were used: mouse CD4-
FITC, CD4-APC, CD27-FITC, CD27-PE, CD62L-PE, CD69-PE, CTLA4-PE, CCR4-
PE (all from Becton Dickinson), CD25-FITC (Dako), CD25-PE (Miltenyi Biotec),
and GITR-PE (R&D Systems).
Cell isolation. Peripheral blood mononuclear cells (PBMC) and synovial fluid
mononuclear cells (SFMC) were isolated by Ficoll-Hypaque (Sigma) density gradient
centrifugation. Following staining for various surface markers, subpopulations of
CD4+  T cells were sorted by FACSVantage (Becton Dickinson). Purity of cell
preparations was typically >97%. Monocytes were isolated from PBMC by positive
selection using CD14-microbeads (Miltenyi). The purified monocytes were cultured
for 3-5 days in RPMI-10% FCS containing 50 ng/ml GM-CSF (Leukomax, Novartis)
and 1000 U/ml IL-4.
Proliferation assay. Peripheral blood CD4+CD25− T cells were labeled with
0.5 µM CFSE (Molecular Probes) for 8 minutes at room temperature. After quenching
of the labeling reaction by addition of RPMI-10% FCS, cells were washed
extensively. Cells (1.5x104) were cultured alone or together with different numbers of
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unlabeled regulatory or control cells in the presence of 103 immature DCs and either 2
ng/ml TSST (Toxin Technology) or 0.25 ng/ml CD3 antibodies (supernatant from
clone OKT3-3). Proliferation was measured on day 4 on a FACSCalibur (Becton
Dickinson) using popidium iodide (Sigma) to exclude dead cells. In some
experiments T cells were stimulated with plate-bound CD3 antibodies (2 µg/ml, from
clone TR66) in the absence or presence of recombinant IL-2 (100 U/ml) or CD28
antibodies (2 µg/ml, Pharmingen).
Real time PCR. For quantitative assessment of relative mRNA levels, total
RNA was prepared from sorted subpopulations using TrizolLS reagent (Invitrogen)
according to the manufacturer’s instructions. RNA was then reverse transcribed using
M-MLV RT reverse transcription kit with random hexamer primers (Invitrogen). The
relative level of FoxP3 mRNA in each subset was determined by real-time PCR on an
ABI PRISM 7700 sequence detector (Applied Biosystems) using the Assay-On-
Demand product for FoxP3 detection (Hs00203958_m1) and universal PCR master
mix (both from Applied Biosystems). The obtained values were normalized to the
amount of 18S rRNA (4310893E, Applied Biosystems) present in each sample. For
detection of relative cytokine mRNA levels, sorted T cell subsets were stimulated for
6 hours with 50 nM phorbol 12,13-dibutyrate (PdBu) (Sigma) and 1µg/ml anti-CD3
(clone TR66) before extraction of total RNA. Cytokine mRNA levels were
determined using Applied Biosystems products for IL-2 (4309882P), TNF
(Hs00174128_m1), and IFN-γ (4327052F).
Cytokine detection assays. IL-7 and IL-15 were measured using commercial
ELISA (R & D Systems) in the sera and synovial fluid of 30 JIA patients (15 with
oligoarticular course and 15 with polyarticular course) and in sera of 12 age-matched
controls that were obtained for routinely preoperative examination before minor
surgery. The assay detection limit was 0.1 pg/ml for IL-7 and 2 pg/ml for IL-15.
Five-cell PCR. For determination of Foxp3 mRNA at a 5-cell level, the four
CD4+ T cell subsets were first sorted by flow cytometry. From each of the purified
subpopulations, 5-cell aliquots were then resorted directly into wells of a 96-well
conic plate. The subsequent procedures for cDNA preparation and nonspecific cDNA
amplification were carried out as described by Bigouret et al. 147. One µl of the
nonspecifically amplified cDNA was used to amplify Foxp3 cDNA with 0.5 µM of
the specific primers Foxp3-F (CACCTACGCCACGCTCATC) and Foxp3-R
                                                                                                                              Results
56
(ACTCAGGTTGTGGCGGATG) (both from Microsynth) in presence of 1.5 mM
MgCl2. As a control, the expression of CD3 was assessed using the primers CD3 S1
( C G T T C A G T T C C C T C C T T T T C T T )  a n d  C D 3  A S 1
(GATTAGGGGGTTGGTAGGGAGTG) (Microsynth). The program used for
amplification was 3 min at 94°C; 30 sec at 94°C, 30 sec at 58°C, 30 sec at 72°C, 40
cycles.
Immunohistochemistry.  Tissue specimens were prepared for
immunohistochemistry according to standard technique. Briefly, specimens were
fixed in 10% formalin for 4 hours, dehydrated and embedded in paraffin. Paraffin
serial sections were stained for 30 minutes at room temperature with mouse
antibodies to CD4 (4B12), CD25 (25C04) , CD27 (137B4) (from Neomarkers), CD20
(L26), CD3 (polyclonal antisera) (from Dako) followed by anti-mouse Ig antibody
conjugated to peroxidase labelled-dextran polymer (EnVision, Dako) and
chromogenic diaminobenzidine substrate (Dako). Slides were counterstained with
Mayer’s hematoxylin. For double immunofluorescence, secondary labeling was
performed, for 30 minutes at room temperature with Alexa Fluor 594 goat anti-mouse
IgG2b (Molecular Probes) and, subsequently, with Alexa Fluor 488 goat anti-mouse
IgG1 (Molecular Probes) to label CD25 and CD27, respectively.
Statistical analysis. Differences in the percentages of matched peripheral
blood and synovial fluid CD4+CD25+ T cells were analyzed by the Wilcoxon matched
pairs signed rank test. Differences in the percentages of CD4+CD25+CD27+ and
CD4+CD25+CD27− and in the amounts of IL-7 and IL-15 in oligoarticular and
polyarticular JIA patients were analyzed by Mann-Whitney U test.
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Abstract
According to the current model, naïve B cell activation is dependent on the sequential
integration of two signals: B cell receptor (BCR) crosslinking by antigen, followed by
cognate interaction with helper T cells through an immunological synapse. Using an
improved method to purify human naïve B cells we found that BCR stimulation and T
cell help induced initial cell division but were not sufficient to promote survival and
differentiation thus leading to abortive proliferation of naïve B cells. Extensive B cell
proliferation, isotypic switch and differentiation to immunoglobulin (Ig)- secreting
cells was induced by addition of microbial products that trigger any of the Toll-like
receptors (TLRs) that are upregulated in naïve B cells upon BCR triggering. TLR
agonists acted directly on B cells and were required irrespective of the nature of the T
helper cells present. Supernatants of dendritic cells (DC) stimulated by DC-specific
TLR agonists were also capable of enhancing B cell responses although to a much
lower and variable extent. These results indicate that human naïve B cell activation is
critically dependent on innate stimuli acting optimally on TLRs expressed by B cells.
The coupling of BCR stimulation to TLR expression endows the human system with
a high degree of specificity since it allows focusing of innate signals only on antigen
stimulated B cells.
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Introduction
Naïve B cell activation is initiated by binding of antigen to the BCR.
Triggered BCRs initiate a signaling cascade that leads to upregulation of
costimulatory molecules and mediate efficient antigen internalization followed by
processing and presentation of antigenic peptides on MHC class II molecules for
recognition by specific T cells 52,53. At the immunological synapse specific T cells are
activated and in turn stimulate B cells via CD40L-CD40 interaction and cytokines 54.
The current dogma is that the timely integration of BCR stimulation (signal one) and
T cell help (signal two) is both necessary and sufficient to drive naïve B cell
proliferation and differentiation to Ig secreting plasma cells 52. Compared to naïve B
cells, memory B cells have looser triggering requirements. For instance human
memory B cells can be readily activated in the absence of BCR stimulation by
bystander T cell help and cytokines 60,148,149.
It has been known for long time that mouse naïve B cells can respond to LPS
and CpG by undergoing extensive proliferation and differentiation, even in the
absence of BCR triggering or T cell help 55,56. Indeed mouse B cells constitutively
express a variety of TLRs, including TLR4 and TLR9, which are triggered by LPS
and CpG 15,57. There is growing evidence that TLRs play an important role in B cell
physiology. Recently it has been shown that particles containing proteins and nucleic
acids can induce autoantibody formation by synergistically engaging BCR and
TLR961-63. However remains to be established whether the BCR-TLR co-engagement
is a general requirement for B cell activation also in the presence of T cell help.
TLRs are differentially expressed in human and mouse B cells. In contrast to
mouse B cells, constitutive TLR expression is restricted to human memory B cells
that express TLR2, TLR6, TLR7, TLR9 and TLR10 but not TLR4 58,59. Consequently
TLR agonists can directly activate human memory but not naïve B cells and it has
been suggested that this selective responsiveness may be a mechanism to maintain
serological memory 60. It was also shown that human naïve B cells upregulate TLRs
following BCR stimulation 58 but it was not established whether and how TLR signals
contribute to human naïve B cell activation.
To define the triggering requirements of naïve B cells it is essential to identify
pure populations and to measure their response in a quantitative fashion. In previous
studies human naïve B cells were isolated according to the expression of IgD 150,151 or
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CD27 152,153. In this study we used an improved method of naïve B cell isolation using
a novel marker, the ABCB1 transporter, that precisely identifies human naïve B
cells66. We show that proliferation and differentiation of human naïve B cells require a
combination of three signals: 1) BCR triggering, 2) cognate T cell help, and 3) TLR
stimulation.
Results
CpG synergizes with BCR triggering and T cell help in activation of human
naïve B cells.
We recently reported that the ABCB1 transporter is expressed on human naïve
B cells and is absent on transitional and memory B cells 66. We used this marker to
isolate highly pure naive B cell populations identified as CD19+ CD27- IgG/A-
ABCB1+ cells (Fig. 1A). Naive B cells were labeled with CFSE and cultured in the
presence of F(ab’)2 fragments of anti human Ig (anti-Ig) and autologous CD4+ T cells
in the presence of the bacterial superantigen TSST as a source of cognate T cell help.
As shown in Figure 1B (upper panel) anti-Ig or T cell help alone failed to induce B
cell proliferation, whereas combination of anti-Ig and T cell help induced B cell
proliferation as measured by CFSE dilution after 5 days. At this time point naïve B
cells had undergone up to 3-4 divisions, but proliferating B cells failed to accumulate
and died after approximately 4 divisions, as detected by the accumulation of
propidium iodide positive cells that had diluted CFSE (Fig.1C). The TLR9 agonist
CpG 2006 had only a marginal effect on naïve B cells when added alone or in
combination with anti-Ig or T cell help (Fig. 1B, lower panel). Remarkably, however,
the combination of anti-Ig, T cell help and CpG led to extensive B cell proliferation
and accumulation of large numbers of B cells that had undergone more than 7
divisions. Thus, CpG potently synergized with BCR triggering and T cell help in
induction of human naïve B cell proliferation.
CpG might synergize in the induction of B cell response by enhancing the
capacity of B cells to stimulate T cells and therefore by boosting T cell help. This
possibility was ruled out by the finding that T cell proliferation was comparable in the
presence or absence of CpG (data not shown) and by the finding that the synergistic
effect of CpG was observed also when soluble CD40L was used as a source of T cell
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help (Fig. 1D). We conclude that sustained B cell proliferation is critically dependent
on microbial stimuli acting on TLR9 expressed by activated naïve B cells.
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Figure 1. TLR9 stimulation provides an essential signal for induction of human naïve B cell proliferation. A) For
isolation of human naïve B cells, peripheral blood CD19+ B cells were labeled with MitoTracker Green FM (MT), stained
for lineage (CD3, CD14, CD16), CD27, and surface IgG and IgA, and sorted by FACS to a purity of > 99.99 %. Upper
panel, before sort; lower panel, after sort. B) CFSE-labeled naïve B cells were stimulated with: i) F(ab’)2-fragments of goat
anti-human Ig (anti-Ig), ii) autologous CD4+ T cells in presence of TSST (T help) and iii) CpG 2006 in various
combinations as indicated and analyzed for proliferation on day 5. Events were acquired for a fixed time to allow a direct
quantitative comparison of B cell proliferation in the different conditions. One representative experiment out of 20. C)
CFSE-labeled naïve B cells were stimulated with anti-Ig and T cell help and analyzed on day 5. Proliferation profiles of
live cells (empty) and dead cells (gray) were determined according to propidium iodide (PI) staining. Shown is one
representative experiment out of six. D) CFSE-labeled naïve B cells were stimulated with anti-Ig, CpG and either T cell
help or recombinant soluble CD40L and IL-2. Shown is one representative experiment out of five.
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The requirements for CpG are observed irrespective of the source of T helper
cells.
We considered the possibility that the requirement for CpG in the induction of
human naïve B cell proliferation might be limited to conditions where T cell help is
suboptimal. Indeed, it has been shown that B cell helper activity is a specialized
function of a subset of memory CD4+ T cells identified by the expression of CXCR5,
also called follicular helper T cells (TFH) 154-156. We therefore compared naïve and
memory subsets of CD4+ T cells for their capacity to trigger naïve B cell proliferation
in the presence or absence of CpG. In the absence of CpG, none of the T cell subsets
was capable of sustaining B cell proliferation and effector memory T cells (TEM) even
appeared to kill naïve B cells (Fig. 2). In contrast, in the presence of CpG all subsets
(with the exception of CD25+ regulatory T cells) induced substantial B cell
proliferation, the highest level being that induced by TFH. We conclude that naïve B
cell activation requires TLR stimulation irrespective of the nature of T helper cells.
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Figure 2. The requirements for CpG are observed irrespective of the source of T helper cells. Naïve B cells were
labeled with CFSE and stimulated as indicated with anti-Ig, CpG and different subsets of autologous CD4+ T cells in
presence of TSST. Proliferation was determined on day 5 by FACS analysis. CD4+ T cell subsets were isolated from
peripheral blood as follows: naïve (TN) CD4+CD45RO-CCR7+, central memory (TCM) CD4+CD45RO+CCR7+CCR5-,
follicular help (TFH) CD4+CD45RO+CCR7+CCR5+, effector memory (TEM) CD4+CD45RO+CCR7-, regulatory T cells
(TREG) CD4+CD45RO+CD25+. Shown is one representative experiment out of four.
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BCR stimulation can be delivered transiently, while T cell help and TLR
stimulation need to be sustained.
We next investigated the temporal requirements for naïve B cell activation. Naïve B
cells were cultured in the presence of anti-Ig, T cell help and CpG. The stimuli were
removed after 24 hours and the cells were recultured in the absence or presence of the
same stimuli alone or in combination (Fig. 3A). Removal of the stimuli after 24 hours
virtually abolished the B cell response measured on day 5. Addition of T cell help or
CpG partially restored the response when added alone and completely restored it
when added together. In all cases the presence of anti-Ig did not show an additive
effect. Furthermore, the anti-Ig signal could be temporally dissociated from T cell
help and TLR signal as shown by the fact that naïve B cells exposed to a short pulse
of anti-Ig became capable of responding to a subsequent addition of T cell help and
CpG (Fig. 3B). We conclude that signal one can be delivered even by a short
stimulation and prepare naïve B cells for subsequent stimulation by T cells and TLR
agonists that need to be sustained in time.
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Figure 3. BCR triggering, T cell help and TLR9 stimulation have diverse functions in human naïve B cell activation.
A) CFSE-labeled naïve B cell were cultured with anti-Ig, T cell help and CpG. Stimuli were either left in culture (black
profile) or removed after 24h. The cells were then recultured in medium alone or in the presence of the indicated stimuli in
the absence (open profiles) or the presence of anti-Ig (filled profiles). Cell proliferation was analyzed on day 5. Shown is
one experiment out of three. B) CFSE-labeled naïve B cells were cultured for one day in medium with or without anti-Ig.
Cells were then washed and cultured in presence or absence of T cell help and CpG for additional 4 days. One
representative experiment out of four.
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TLR agonists provide signal three either directly on B cells or indirectly through
DC activation.
Upon BCR triggering naïve B cells upregulate several TLRs. We therefore
tested an array of TLR agonists for their capacity to promote B cell proliferation when
combined with anti-Ig and T cell help. All agonists of TLRs expressed by activated
human B cells were capable of synergizing with BCR triggering and T cell help (Fig.
4A). In contrast, poly(I:C) and LPS failed to provide such signals, consistent with the
absence of TLR3 and TLR4 in human B cells. Extensive B cell proliferation was
observed also in the presence of E. coli DNA or live bacteria that contain agonists of
TLR2 and TLR9.
Figure 4. TLR agonists provide signal three either directly on B cells or indirectly through DC activation A)
CFSE-labeled naïve B cells were cultured in the presence of anti-Ig, T cell help and an array of TLRs agonists including
E. coli DNA and intact bacteria. Shown is the proliferative response on day 5 in one representative experiment out of six.
B) Immature monocyte-derived DCs were either left untreated or activated with LPS or poly(I:C). Supernatant was
collected after 24h and added at an optimal concentration (10%) to naïve B cells in presence of anti-Ig and T cell help.
Shown is the relative increase of proliferating B cells that had undergone more than four divisions in supplemented
cultures compared to control cultures (medium). Data represent mean +/- stdev of 4 experiments using DC supernatants
from 12 donors.
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While poly(I:C) and LPS were not able to directly stimulate B cells, we
noticed that the supernatant of poly(I:C)- or LPS-activated DCs was able to synergize
with anti-Ig and T cell help in induction of B cell proliferation. However the effect
was variable and much lower as compared to the effect of direct TLR stimulation
(Fig. 4B). To identify a putative activity in these supernatants we tested the effect of
neutralizing antibodies against a variety of cytokines and found that anti-IL-6 and
anti-IL-12 abolished the stimulatory effect of supernatants of LPS-activated DCs,
while antibodies to IL-10 had no effect (Supplementary Fig. 1A). Furthermore,
addition of recombinant IL-6 and IL-12 was able to increase proliferation of B cells
triggered by anti-Ig and T cell help (Supplementary Fig. 1B).
We conclude that signal three can be delivered to B cells by a variety of
microbial products acting directly on the TLRs expressed on B cells or indirectly
through activation of DCs and release of cytokines, primarily IL-6 and IL-12.
TLR stimulation is required for induction of class switch and plasma cell
differentiation.
Class switch recombination requires the B-cell-specific activation-induced
cytidine deaminase protein (AID), which initiates this reaction through its single-
stranded DNA-specific cytidine deaminase activity 157. Although anti-Ig and T cell
help were able to promote naïve B cell proliferation by day 4, the divided cells failed
to upregulate AID mRNA (Fig. 5A). In contrast, AID mRNA was markedly
upregulated on day 4-B cells stimulated by anti-Ig, T cell help and CpG. Furthermore
surface IgG or IgA were detectable by day 6 in a fraction (5-15%) of B cells primed
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Supplementary Figure 1. IL-12 and IL-6
are produced by TLR-stimulated DC
and synergize with anti-Ig and T cell
help in naïve B cell activation. A) Naïve
B cells were stimulated with anti-Ig, T cell
help and supernatants of LPS-stimulated
DCs in the presence of neutralizing
antibodies to IL-6, IL-10, or IL-12. Open
profiles indicate proliferation in absence
and overlaid filled profiles in presence of
neutralizing antibodies. Shown is one
representative experiment out of four. B)
B cells were activated with anti-Ig and T
cell help in presence of recombinant
human IL-6 and IL-12. One representative
experiment out of six.
                                                                                                                              Results
65
by the three stimuli (Fig. 5B). Thus, in these culture conditions, isotype switch is
critically dependent on TLR stimulation.
The differentiation of B cells to plasma cells is an irreversible process
mediated by X-box binding protein-1 (Xbp-1) 158. The addition of CpG to naïve B cell
cultures stimulated with anti-Ig and T cell help was essential for the sustained
upregulation of Xbp-1 mRNA (Fig. 5C) and for the differentiation of naïve B cells to
antibody-secreting cells (Fig. 5D). We conclude that TLR stimulation plays an
essential role also in induction of isotypic switch and B cell terminal differentiation.
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Figure 5. TLR stimulation is required for induction of isotypic switch and differentiation to Ig-secreting cells. A)
and C) Naïve B cells were left untreated (open circles), stimulated with anti-Ig and T cell help (open triangles); anti-Ig and
CpG (open square); anti-Ig, T cell help, and CpG (filled square). On the indicated days, living B cells were isolated by cell
sorting and mRNA levels for AID (A) or Xbp-1 (C) were determined by quantitative real-time PCR and normalized to the
amount of 18S rRNA. One experiment out of two. B) CFSE-labeled naïve B cells were stimulated as indicated and stained
for surface IgG (upper panel) or IgA (lower panel) on day 6. Shown is one representative experiment out of ten. D)
Cultures were set up as above and immunoglobulin secreting cells (ISC) were determined by ELISPOT on day 7. IgM,
filled bars, IgG, hatched bars. IgA, open bars. Data represent mean +/- stdev of eleven experiments.
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Discussion
We have shown that TLR stimulation provides a third signal that synergizes with
BCR triggering (signal one) and T cell help (signal two) resulting in the induction of
sustained proliferation and differentiation of human naïve B cells. While signal one
and two together are sufficient to drive initial proliferation of naïve B cells, they fail
to sustain B cell expansion and the proliferating B cells die after a few divisions. TLR
stimulation rescues proliferating B cells that progressively switch isotype and
differentiate to plasma cells, two events that are known to be division dependent 159.
TLR stimulation augments the frequency of naive B cells that enter the first division
(as shown by a reduced peak of undivided cells) and promotes at the same time
accumulation of cells at late divisions. This finding is consistent with the report that
CpG provides signals that promote cell cycle entry and cell survival 160.
The mechanism by which TLR signaling interplays with signals transduced by
BCR or CD40 remains to be determined. We have shown however that there are
different temporal requirements for delivery of the three signals. While signal one can
be delivered by transient BCR triggering, signals two and three have to be sustained
in time in order to induce maximal clonal expansion. This observation is consistent
with the notion that BCR triggering leads to upregulation of costimulatory molecules
and TLRs and suggests that a main function of BCR triggering is to enable B cell
responsiveness to T cell- and innate immunity-derived signals.
All agonists that trigger TLRs upregulated on activated human naïve B cells
were capable of providing signal three. The fact that these stimuli were effective only
when given together with signal one and two underlines a remarkable difference
between human and mouse B cells. Indeed, mouse naïve B cells constitutively express
TLR4 and TLR9 and can be polyclonally stimulated by the cognate agonists, while
human naïve B cells respond to TLR agonists only after initial BCR stimulation. Thus
the coupling of BCR stimulation to TLR expression endows the human system with
an additional degree of specificity, since it focuses innate signals only on antigen
stimulated B cells.
Another difference between human and mouse B cells is the spectrum of
TLRs expressed. For instance, while mouse B cells express TLR4 and respond to
LPS, human B cells do not express TLR4 and responsiveness to LPS is restricted to
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DCs 58,59. We exploited this fact to show that human DCs stimulated by LPS release in
the culture supernatant cytokines, primarily IL-6 and IL-12, which sustain naïve B
cell activation. A positive effect of DCs and IL-12 on human B cell activation have
been previously reported 161.
It is intriguing that similar effects on B cell proliferation and survival could be
induced by both TLRs and cytokine receptors, which engage different signaling
pathways. Redundant mechanisms promoting survival of dividing cells might be the
basis of this biological effect. It should be noticed however that the stimulatory
capacity of TLR-activated DCs is quantitatively much lower and more variable as
compared to direct stimulation of TLRs on B cells. It remains to be established
whether the nature of signal three (type of TLR or cytokine) may impact on the
quality of the B cell response generated, for instance in terms of isotypic switch or
memory B cell differentiation 162.
In conclusion, we demonstrate that human naïve B cells (as naïve T cells)
have very strict requirements for priming. The essential necessity for a TLR-derived
third signal for naïve B cell activation extends to the human system the recent notion
that mouse B-cell responses are controlled by TLR 65. Our results imply that TLR
agonists can amplify and sustain specific B-cell responses induced by conventional T-
dependent antigens and strongly support the concept for inclusion of selected TLR
agonists in vaccine formulations 163.
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Materials and methods
Media and reagents. The medium used throughout was RPMI 1640
supplemented with 10% FCS (Hyclone), 1% Glutamax, 1% nonessential amino acids,
1% pyruvate, 50 U/ml penicillin, 50 µg/ml streptomycin, 5x10-5 M 2-mercaptoethanol
(all Invitrogen). Recombinant human IL-6 and IL-12 were purchased from BD
Biosciences.
FACS analysis. The following monoclonal antibodies were used: mouse anti-
human CD3-PC5, CD4-PC5, CD4-APC, CD14-PC5, CD16-PC5, CD27-PE, CD86-
PE, purified CXCR5, BrdU-PE, Annexin V-PE (all from BD Biosciences), CD45RO-
FITC (Beckman Coulter) goat anti-human IgG-PE, IgG-Cy5, IgA-Cy5 (all from
Jackson ImmunoResearch), mouse anti-human CD25-PE (Miltenyi), rat anti-human
CCR7 (clone 3D12, kindly provided by M. Lipp, Berlin-Buch, Germany).
Cell isolation. Peripheral blood mononuclear cells (PBMCs) were isolated by
Ficoll-Hypaque density gradient centrifugation. CD4+ T cells and CD19+ B cells were
isolated by use of CD4 and CD19-microbeads (Miltenyi), respectively, according to
the manufacturer’s instruction. B cells were labelled with 25 nM MitoTracker Green
FM (Molecular Probes), a substrate for ABCB1, for 25 minutes at 37°C and washed
two times. Following staining for lineage (CD3, CD14, CD16), CD27, and surface
IgG and IgA, naïve B cells were double sorted by FACSAria (Becton Dickinson) with
a purity of >99.9%. Beads-purified T cells were stained for expression of CD4,
CD45RO and in some experiments also for CD25, CCR7, and CXCR5 and sorted by
FACSAria. Purity of T cell preparations was typically >98%. Monocytes were
isolated from PBMCs by positive selection using CD14-microbeads (Miltenyi). The
purified monocytes were cultured for 3-5 days in RPMI-10% FCS containing 50
ng/ml GM-CSF (Leukomax, Novartis) and 1000 U/ml IL-4. Monocyte-derived DCs
were then washed twice, seeded at 1x106/ml and stimulated with 100 ng/ml LPS
(E.coli 055:B5 LPS, Sigma) or 20 µM poly(I:C) (Amersham) for 24h.
Proliferation assay. Peripheral blood CD3-CD14-CD16-CD19+CD27-IgG-IgA-
ABCB1+ naïve B cells were labeled with 0.5 µM 5- and 6-carboxyfluorescein
diacetate succinimidyl ester (CFSE, Molecular Probes) for 8 minutes at room
temperature. After quenching of the labeling reaction by addition of RPMI-10% FCS,
cells were washed extensively. Cells (1x104) were cultured in 96 well round-bottom
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culture plates with different combinations of the following stimuli: 2.5 µg/ml F(ab’)2
anti-human IgM/IgG/IgA (Jackson ImmunoResearch), 1µg/ml CD40 ligand plus 1
µg/ml enhancer (Alexis), 2x104 irradiated (20 Gy) T cells in the presence of 0.5 ng/ml
TSST (Toxin Technology), 2.5 µg/ml CpG oligodeoxynucleotide 2006 (5’-
TCGTCGTTTTGTCGTTTTGTCGTT-3’, Microsynth), 2.5 µg/ml R848
(GLSynthesis), 10µg/ml MALP-2, 1 µg/ml Pam3CSK4, 1 µg/ml flagellin (all from
InvivoGen), 100 ng/ml LPS, 20µM poly(I:C), 10 ng/ml IL-6/IL-10/IL-12, or 24 h DC
supernatant at a final dilution of 1:10. Bacterial genomic DNA was isolated from
E.coli DH5α (Invitrogen) using Trizol LS reagent (Invitrogen) according to the
manufacturer’s instructions and used at 10µg/ml for B cell stimulation. Live E.coli
DH5α  were cocultivated with B cells at a ratio of 100:1 in medium without
penicillin/streptomycin. Proliferation was measured on day 5 on a FACSCalibur (BD
Biosciences) using PI (Sigma) and CD3-PC5 to exclude dead cells and remaining T
cells. Acquisition was done for a fixed time to allow quantitative read-out.
Real time PCR. For quantitative assessment of relative mRNA levels, total
RNA was prepared from FACS-sorted populations using Trizol LS reagent according
to the manufacturer’s instructions. RNA was then reverse transcribed using M-MLV
RT reverse transcription kit with random hexamer primers (Invitrogen). The relative
mRNA levels were determined by real-time PCR on an ABI PRISM 7900HT
sequence detector (Applied Biosystems) using the Assay-On-Demand product for
AID (Hs00221068_m1) and Xbp-1 (Hs00231936_m1) together with universal PCR
master mix (4352042) (all from Applied Biosystems). The obtained values were
normalized to the amount of 18S rRNA (4310893E, Applied Biosystems) present in
each sample.
ELISPOT. Ig-secreting cells (ISC) were detected by ELISPOT on day 7. Filter
plates (Millipore MAIPS4510) were coated with 5 µg/ml purified goat anti-human
IgM, IgG, or IgA (Southern Biotechnology) and subsequently blocked with PBS
containing 1% BSA (Sigma). Serial dilutions of cells were added to the plates and
incubated overnight at 37°C. Plates were then washed with PBS/0.05% Tween 20
(Fluka) and incubated with biotinylated isotype-specific secondary antibodies
(Southern Biotechnology) followed by streptavidin-horseradish peroxidase (Sigma).
The assay was developed with 3-amino-9-ethylcarbazole (AEC, Sigma) as
chromogenic substrate.
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Addendum: methods developed for the study
In vitro system for quantification of suppressive activity
Suppressive activity of regulatory T cells is generally determined by
measuring the incorporation of radioactive 3H-thymidine during DNA replication in
cultures containing conventional T cells together with different numbers of Treg in
presence of irradiated APC. As Tregs are anergic and assumed not to proliferate under
such conditions, measured total 3H-thymidine incorporation is interpreted as due to
proliferation of only conventional T cells. 3H-thymidine incorporation determines
suppression during the final hours of the experiment and therefore represents a
snapshot of the end-point. It is not possible to track the overall outcome of
suppression nor is it possible to obtain qualitative information about the proliferating
T cells as the number of cell divisions they have undergone, the fraction of cells that
proliferate, or the viability of cells in culture.
To allow a more detailed analysis of regulatory T cell activity, we aimed to set
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Figure 1. CFSE-based tracking of responder cell division in cocultures of CFSE-labeled conventional and
unlabeled regulatory T cells detects suppressor activity. A) 1.5 x 104 CFSE-labeled conventional CD4+ T
cells were cocultivated with the indicated number of Treg in presence of 1000 immature DC and 0.25 ng/ml anti-
CD3 in triplicate cultures. Responder cell proliferation was determined on day 4 by FACS analysis as in Fig.1.
Depicted is one representative plot per condition showing responder cell proliferation in absence (open
histograms) or presence (filled histograms) of Treg. B) Responder cells that had undergone one or more cell
divisions were quantified in each condition. Depicted is the mean +/- stdev of triplicate cultures. C) The
percentage of inhibition by decreasing numbers of Treg was calculated using as a reference the proliferation of
responder cells in absence of Treg (defined as 0 % inhibition).
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up a novel in vitro system for quantification of suppression by human Tregs by use of
CFSE dilution analysis. We labeled conventional T cells with CFSE, cocultivated
these “responder cells” with Tregs and immature DC in presence of soluble anti-CD3
(clone Okt3). Responder cell proliferation was analyzed by FACS on day 4 by
excluding PI+ dead cells and CFSE- Tregs. Acquisition was done for a fixed time on a
fixed volume to allow quantitative comparison of the different conditions. The
number of responder cells that underwent one or more cell divisions was determined
in each condition, and the extent of suppression was quantified by calculating the
percent reduction in cultures containing Tregs as compared to control cultures without
Tregs (figure 1). Tracking of responder cell proliferation by CFSE dilution analysis
sensitively detected dose-dependency of suppression by Tregs, also at very low
numbers of Tregs as at a ratio of 1:64.
To confirm the reliability of the established CFSE-based suppression assay,
we determined the suppressor activity of Tregs in parallel using both 3H-thymidine
incorporation and CFSE-dilution as read-out (figure 2). Results obtained from both
assays were comparable although remarkably the CFSE-based assay was consistently
more sensitive as shown by an increase of suppression at a 1:1 ratio (95% suppression
by CFSE dilution analysis versus 83% suppression by 3H-thymidine incorporation)
and a decreased number of Tregs required for 50% inhibition of responder cell
proliferation (1:3 for 3H-thymidine incorporation and 1:7 for CFSE dilution analysis).
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Figure 2. Detection of suppressor activity by CFSE dilution analysis and by 3H-thymidine
incorporation output similar results. For detection by CFSE dilution analysis (black square) 1.5x104
CFSE-labeled CD4+ responder T cells were cocultivated with titrated numbers of autologous Treg in
presence of iDC and anti-CD3. Cultures were analyzed on day 4 by FACS analysis, and numbers of
responder cells that had undergone one or more cell divisions were quantified for every condition. For
detection by 3H-thymidine incorporation (black triangle) 1.5x104 unlabeled CD4+ responder T cells were
cocultivated with titrated numbers of autologous Treg in presence of iDC and anti-CD3. After 84h of
cultivation cultures were pulsed for 12 hours with 1 µCi/well 3H-thymidine. Proliferation was measured
using a liquid scintillation counter. Percent inhibition was determined by calculating the reduction of
proliferation in cultures containing Treg as compared to cultures without Treg.
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This increase in sensitivity could be either due to determination of overall suppression
instead of a final snapshot or due to tracking of only responder cell proliferation while
excluding contaminating Treg proliferation.
As most research on Tregs is done in the mouse system, we aimed to
determine whether a similar approach could be used also for detection of suppression
activity by mouse Treg. CD4+CD25- and CD4+CD25- T cells were sort purified from
BALB/c splenocytes. CD4+CD25- responder T cells were labeled with CFSE and
cultured with titrated numbers of CD4+CD25+ Treg in presence of syngeneic iDC and
soluble anti-CD3 (clone 145-2C11). Proliferation of responder T cells was determined
on day 4 by FACS analysis by excluding PI+ dead cells and CFSE- Treg. As shown in
figure 3 the reduction of responder cell proliferation by mouse Treg was 80-90% at
1:1 ratio with 50% reduction at ratio of 1:8, which is similar to values reported in
literature.
We conclude that the CFSE-based in vitro suppression assay is well suited to
characterize in a sensitive way quantitative and qualitative aspects of in vitro
regulation of T cell responses in the mouse and the human system.
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Figure 3. CFSE-based detection of suppressor activity of mouse Treg. A) 2.5 x 104 CFSE-labeled conventional
CD4+ T cells were cocultivated with the indicated number of Treg in presence of 2000 immature DC and 0.1 ng/ml
soluble anti-CD3 (clone 145-2C11) in duplicate cultures. Responder cell proliferation was determined on day 4 by
FACS analysis. Depicted is one representative plot per condition showing responder cell proliferation in absence (open
histograms) or presence (filled histograms) of Treg. B) Responder cells that had undergone one or more cell divisions
were quantified in each condition. Depicted is the mean +/- stdev of duplicate cultures. C) The percentage of inhibition
by decreasing numbers of Treg was calculated using as a reference the proliferation of responder cells in absence of
Treg (defined as 0 % inhibition).
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Determination of TCR specificity of anergic T cells
For the determination of TCR specificity of Treg we had to establish a
method, by which we could overcome the anergic state of Treg and easily detect TCR
signaling. Our strategy was to generate T cell hybridomas by fusion of purified
populations of Treg or conventional T cells, which were preactivated for 3 days with
anti-CD3 and anti-CD28 in presence of IL-2, with TCR-negative thymomas (BW5147
derivatives containing GFP under the control of NFAT as a reporter gene) using
standard protocols for PEG-mediated fusion followed by selection in HAT medium.
The resulting hybridomas bear TCR of initial T cells but have lost anergic behavior
and can be assessed directly for TCR specificity by determination of GFP-expression
upon TCR stimulation.
Eight GFP-transfected thymoma clones were tested for their ability to fuse
with mouse CD4+ T cells. The obtained hybridomas were screened for expression of
GFP upon TCR stimulation by plate-bound anti-CD3 (figure 4). The thymoma clone
7.21 was chosen as fusion partner for further experiments as it gave rise to
hybridomas expressing high levels of GFP upon TCR stimulation.
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Figure 4. Evaluation of potential fusion
partners. CD4+ mouse T cells were activated
in vitro and fused by PEG with the indicated
GFP-transfected thymoma-derivates at a 1:1
ratio. Single clones were expanded in HAT-
medium for 2 weeks. Hybridomas were then
stimulated overnight with plate-bound anti-
CD3 and analyzed for GFP-expression by
FACS. Depicted are the overlays of all TCR-
stimulated hybridomas derived from the
indicated thymomas.
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More than 98% of the obtained hybridomas responded to anti-CD3 stimulation
by expression of GFP. The percentage of GFP+ cells in anti-CD3 stimulated
hybridomas, defined as maximal response, varied between single hybridomas between
0-100% (figure 5). Hybridomas responding with a maximal response of less than 20%
were not included in the analysis. The maximal response was identical in populations
derived from Treg and from conventional T cells, which implies that the anergic state
of Treg does not impact on the responsiveness of hybridomas.
To test the responsiveness of such hybridomas to self-antigens we used T cells
from the AbEpli- mouse (“single peptide mouse” 102), in which I-Ab MHC II
molecules are covalently linked to a single defined peptide and therefore thymic
negative selection to self-antigens cannot occur. I-Ab MHC II wild-type and single
peptide mouse-derived iDC were CMTMR-labeled and pulsed overnight with a lysate
of multiple mouse tissues to provide a source of tissue-specific as well as
ubiquitously-expressed self-antigens. Hybridomas were then cocultivated with the
self-antigen presenting DC and analyzed for the expression of GFP. To account for
the observed large differences in maximal responses, results were expressed in
percent of maximal responses. When stimulated with single peptide mouse-derived
DC, on which the initial T cells were negatively selected in thymus, no hybridomas
responded strongly (>25% maximal response) and less than 5% responded weakly
(>1% maximal response). In contrast, when stimulated with syngeneic wild-type DC,
more than 40% of single peptide-derived hybridomas responded strongly to self-
antigenic stimuli, and more than 75% responded weakly (figure 6, see manuscript 1).
Figure 5. Maximal GFP-expression
upon TCR-stimulation is similar in
Treg- and conventional T cell-
derived hybridomas. A) 7.21-derived
hybridomas were stimulated overnight
with plate-bound anti-CD3 and
analyzed for GFP-expression by
FACS. Depicted are representative
plots showing hybridomas with
maximal GFP-expression of 20-80%.
B) Depicted is the distribution of
maximal GFP-expression in
hybridomas derived from Treg (empty
square) or conventional T cells (filled
square).
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We deduce that the system we have established allows detecting of TCR
stimulation by determination of GFP expression in activated hybridomas. Self-
reactive T cells are easily detected with this system. As T cell hybridization
overcomes the anergic state of regulatory T cells, we have developed a tool to directly
compare the extent of TCR triggering in pools of peripheral Treg and normal T cells
upon stimulation with self-antigen.
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Figure 6. Detection of broad self-
reactivity in hybridomas derived from T
cells that did not undergo thymic
negative selection for self-antigens.
Hybridomas were produced from CD4+ T
cells obtained from single peptide mice.
Hybridomas were activated overnight with
plate-bound anti-CD3 and with DC pulsed
with self-tissue extracts, and GFP-
expression was determined by FACS
analysis. Shown is GFP-expression upon
self-antigen stimulation by autologous
single-peptide DC (open triangles) or by
syngeneic BALB/c DC (filled triangles)
expressed as percentage of maximal
response obtained upon anti-CD3
stimulation.
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Gene expression analysis on populations of limiting cell numbers
Current methods for determination of gene expression on a transcriptional
level base on the measurement of mRNA content in bulk populations by quantitative
PCR. Heterogeneity of populations in terms of differential gene expression in
individual cells cannot be assessed by use of these methods. In complex tissues as the
sites of autoimmune reactions that contain heterogeneous populations of cells in
different activation states, such methods are therefore only of limited use. To address
the question of how to distinguish Treg from activated T cells in a pool of
CD4+CD25+ T cells from inflamed tissue, we aimed to establish a sensitive method
for characterizing gene expression in populations of limiting cell numbers. To
establish this tool we used a modified protocol based on 147.
In short, cells were sort-purified and deposited at limiting cell numbers into
96-well V-bottom culture plates containing combined lysis buffer and cDNA mix
solution. Following reverse transcription, cDNA was ethanol precipitated in order to
eliminate inhibiting components of lysis buffer/cDNA mix. Tailing of cDNA with
homopolymeric dA by use of TdT allowed subsequent nonspecific amplification by
oligo-dT primers. Detection of FoxP3 cDNA was performed either by conventional
semiquantitative PCR or by quantitative real-time PCR; as internal control for
quantification of total cDNA per sample we determined the amount of CD3 and beta-
actin cDNA respectively.
To determine the minimal amount of
cells necessary for obtaining reliable signals,
CD4+ T cells from healthy donors were sort-
purified and deposited at one or five cells per
well. Samples were processed as described, and
the quantity of beta-actin mRNA in each sample
was determined by quantitative real-time PCR.
Figure 7 shows the amount of beta-actin
transcripts in samples containing 1 or 5 cells
each. The difference in beta-actin signal was
roughly 7 fold (5.1x10-12 for 1 cell and 3.7x10-11
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Figure 7. Determination of minimal cell
number required for reliable gene
expression analysis. Five replicates of
samples containing one or five cells each
were analyzed for beta-actin expression by
quantitative real-time PCR. Shown is the
intensity of the beta-actin signal per sample.
Red dotted line: mean of five replicates
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for 5 cells) thus reflecting the expected five-fold
difference from the cellular input. However, while all
samples scored positive for beta-actin signals when 5
cells were analyzed together, one out of 5 was
negative when only one cell was detected. In addition,
Ct values were all higher than 35 cycles for single cell
analysis thus increasing the risk of low reproducibility.
To avoid signals near detection limits, subsequent
analysis was performed on populations of 5 cells each.
Next we applied 5-cell PCR to the analysis of
CD4+CD25+CD27+ Treg from peripheral blood (PB) or
synovial fluid (SF) of JIA patients. Determination of
highly expressed genes as CD3 was performed by
semiquantitative PCR and revealed 100% positive samples from both PB and SF
(figure 8a). Similarly expression of beta-actin could be detected by real time PCR in
all samples (data not shown). These results indicate a solid functioning of the method.
To measure cDNA levels of genes expressed at a low level, Foxp3 cDNA was
measured by semiquantitative PCR in the same samples. While Foxp3 cDNA could
be detected in all samples extracted from SF, no expression was detected in PB-
derived samples (figure 8b). To increase
the sensitivity of the assay, we determined
FoxP3 cDNA levels by real-time PCR and
were able to detect low Foxp3-expression
also in PB CD4+CD25+CD27+; the
difference in expression level between the
corresponding subsets in PB and SF was
around 2000 fold (figure 9). Measurement
of cDNA levels by real-time PCR therefore
increases the sensitivity of the assay over
several log scales.
In conclusion, our results demonstrate that 5-cell-PCR is a sensitive tool for
analysis of both high-level and low-level gene expression in populations of limiting
cell numbers.
CD3
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Figure 8. Detection of high-level
gene expression in samples of
limiting cell numbers by semi-
quantitative PCR. A, B) Gene
expression of CD3 (A) and Foxp3
(B) was analyzed by semi-
quantitative PCR in eight replicates
of five cells each isolated from PB
(upper panel) and SF (lower panel).
Gene-specific PCR products were
visualized on a 3% agarose gel.
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Figure 9. Detection of low-level gene
expression by quantitative real-time PCR.
Eight replicates of PB and SF Treg containing
five cells each were analyzed for Foxp3
expression by real-time PCR. Shown is the
intensity of the Foxp3 signal in each sample. Red
dotted line: mean of eight replicates
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In vitro culture system for delivery of cognate T cell help to
polyclonal B cell populations
In vitro cultivation of human naïve B has been observed to be difficult because
of low responsiveness of naïve B cells to widely used polyclonal B cell stimuli as
CD40L or CpG. An obvious explanation for this finding is that processes occurring
during T-dependent B-cell activation are mimicked in a suboptimal way by the current
in vitro cultivation systems. For antigen binding (signal one) good mimicry can be
achieved by use of anti-Ig antibodies that crosslink surface Ig on B cells. In contrast,
exact mimicry of T cell help (signal two) is difficult because of the polyclonality of
human T and B cells, which precludes cognate interaction of antigen-presenting B
cells with the corresponding specific T cells. Artificial systems as soluble CD40L or
CD40L transfectants deliver only a limited set of signals, while additional signals
delivered by activated T cells as cytokines or other interacting surface molecules
cannot be induced. In addition the use of – in most cases nonhuman – CD40L
transfectants bears the risk of inducing uncontrolled xenospecific B cell responses.
Finally irradiated CD40L transfectants that die during cultivation increase the amount
of genomic DNA released into culture. As mammalian genomic DNA has been shown
to stimulate TLR9 61,63,164 such transfectants might additionally deliver signals
activating innate immunity.
We thus aimed to establish a novel culture system that allows inducing cognate
interactions between autologous polyclonal human T and B cell populations. We
hypothesized that crosslinking of MHC II on B cells with TCRs by superantigens as
TSST could induce B cell-T cell interactions similar to cognate interactions. To test
this prediction we cultured human naïve B cells with anti-Ig and CpG in presence or
absence of autologous T cells and TSST. The presence of either T cells or TSST alone
did not influence proliferation of B cells in response to BCR triggering and TLR9
stimulation. In contrast, the addition of T cells in presence of TSST augmented the
number of proliferating B cells in culture in a dose-dependent way (figure 10). We
deduce that TSST induces potent interaction between polyclonal human B cells and T
cells.
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To compare the effect of direct cognate T cell help with currently used culture
systems mimicking T cell help, we cultured human naïve B cell with anti-Ig and CpG
in absence or presence of autologous T cells plus TSST or soluble CD40L. We found
that cognate T cell help increased the number of proliferating B cells in culture and
induces accumulation of B cells that have undergone more divisions as compared to
stimulation with purified CD40L (figure 11). We conclude that direct cognate T-B cell
interaction is superior to stimulation of B cells with commercial CD40L.
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Figure 10. TSST induces potent
interaction between polyclonal
human B and T cell populations. A)
1.5x104 CFSE-labeled human naïve B
cells were cultured with 2.5µg/ml anti-
Ig and 2.5µg/ml CpG in absence or
presence of 0.5 ng/ml TSST and
0.5x104 autologous T cells.
Proliferation was determined on day 5
by FACS analysis using PI and anti-
CD3 to exclude dead cells and T cells.
Acquisition was done for a fixed time
on a fixed volume to allow quantitative
read-out. B) 1.5x104 CFSE-labeled
human naïve B cells were cultured with
2.5µg/ml anti-Ig, 2.5µg/ml CpG and
0.5x104 autologous T cells in presence
of the indicated concentrations of
TSST. Proliferation was determined on
day 5 by quantitative FACS analysis.
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500 Figure 11. Stimulation with T cells is more potent than stimulation with CD40L. CFSE-
labeled human naïve B cells were cultured with anti-Ig and CpG in absence (black
histogram) or presence of either T cells plus TSST (empty histogram) or soluble CD40L
(grey histogram). Proliferation was determined by quantitative FACS analysis on day 5.
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Conclusions
Balancing forces of suppressing and enhancing nature determine the response
of the immune system. In this thesis work two issues related with suppression of T
cell responses by Tregs were addressed, namely the specificity of Tregs for self and
their identification in inflamed tissues. In addition it was established that microbial
products acting on TLRs provide essential enhancing signals required for induction of
naïve B cell responses.
Lack of autoreactivity among regulatory T cells
The current theory of Treg activity predicts that Tregs are of increased self-
specificity, become activated by immature self-antigen presenting DC and suppress
activation of conventional T cells by these iDC. Their mode of action is therefore
expected to be self-antigen-specific 33. Recent studies however show that transduction
of normal, nonself-specific T cells with the Foxp3 transgene induces Tregs with
comparable suppressive activity as naturally arising Treg 23,24 - a finding that stands in
contradiction to the previously mentioned model and suggests that self-specificity is
no requirement for Treg activity.
The extent of self-specificity of TCRs derived from Tregs or conventional T
cells was determined using T cell hybridization as a way to overcome Treg anergy.
Analysis of more than 350 TCRs from both T cell populations revealed no TCRs of
high self-reactivity. In contrast large numbers of highly self-reactive TCRs were
detected in hybridomas derived from single peptide mouse T cells that did not
undergo negative selection for self-antigens 102. These results suggest that Tregs are
not of increased self-specificity as compared to conventional T cells. Moreover, the
very low frequency of weakly self-reactive Tregs renders it rather unlikely that self-
reactivity is of essential importance for Treg function.
This finding implies that Tregs and conventional T cells express similar TCR
repertoires and recognize similar antigens. As a consequence the hypothesis arises
that T cell activation is automatically followed by induction of a Treg-mediated
negative control and is only overcome in case of microbial danger 18. The control of
Treg function may therefore be rather context-dependent than self-antigen-dependent.
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Identification of regulatory T cells by coexpression of CD25 and
CD27
The function of Tregs in the control of ongoing autoimmune reactions is only
poorly characterized, mainly because of a lack of Treg-specific surface markers: in an
inflamed tissue CD4+CD25+ Treg cannot be discriminated from activated
conventional T cells, which express the same surface markers as Tregs, and thus
Treg-specific analysis is precluded in such settings. The discovery of reliable markers
capable of discriminating Tregs from activated T cells in such conditions is therefore
essential for a better understanding of the role of Tregs in autoimmune diseases as
well as for the development of therapeutic applications.
By dissecting the CD4+CD25+ compartment isolated from synovial fluid of
JIA patients into further subpopulations we have found that in inflamed tissue co-
expression of CD25 and CD27 defines Foxp3+ cells with suppressive activity, while
CD25+CD27- cells are devoid of Foxp3 and regulatory activity. In the resting state a
large fraction of CD4+ T cells express CD27; CD27 expression per se is therefore not
specific for Treg. Upon activation however, only regulatory but not conventional T
cells maintain high expression of CD27. This differential regulation of CD27 in Tregs
as compared to conventional T cells allows discriminating the two populations in
complex inflamed tissues.
Using this novel Treg marker it was shown that Tregs isolated from the site of
autoimmune reaction are fully functional and suppress T cell proliferation in vitro. A
cell-intrinsic defect of Tregs as autoimmunity-promoting factor can therefore be
excluded. In contrast, we have observed that inflammatory cytokines as IL-7 and IL-
15, which are present in the milieu of autoimmune disease, potently block Treg-
mediated suppression in vitro. The in vivo concentration of these cytokines correlated
with the severity of the disease, which underlines the importance of Treg activity on
the control of disease progression and suggests a mechanism, in which the
inflammatory milieu itself potentates the autoimmune disease by inhibiting Treg-
mediated suppression.
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Microbial products deliver an essential third signal required for
induction of human naïve B cell responses
Enhancing mechanisms capable of overcoming suppressing activity are
generally induced upon detection of microbial invasion and are therefore linked with
recognition of a context of microbial danger. Context discrimination, mediated by
TLRs, determines the stimulatory capacity of DC and is therefore essential for
induction of productive T cell responses.
In this thesis work we show that TLR triggering is also critically required for
the induction of B cell responses. TLR stimulation provides a third signal that
synergizes with BCR triggering (signal one) and T cell help (signal two) resulting in
the induction of sustained proliferation and differentiation of human naïve B cells.
While signal one and two together are sufficient to drive initial proliferation of naïve
B cells, they fail to sustain B cell expansion and the proliferating B cells die after a
few divisions. TLR stimulation rescues proliferating B cells that progressively switch
isotype and differentiate to plasma cells.
TLR stimulation supports B cell responses by multiple pathways: it augments
the frequency of naïve B cells that enter the first division and promotes accumulation
of cells at late divisions. TLR triggering was effective only when given together with
signal one and two, which underlines a remarkable difference between human and
mouse B cells. Indeed, mouse naïve B cells constitutively express TLR4 and TLR9
and can be polyclonally stimulated by the cognate agonists, while human naïve B
cells respond to TLR agonists only after initial BCR stimulation. The coupling of
BCR stimulation to TLR expression endows the human system with an additional
degree of specificity by focusing innate signals only on antigen stimulated B cells.
In conclusion, we demonstrate that human naïve B cells (as naïve T cells)
have very strict requirements for priming. Besides recognition of the specific antigen
and cognate interaction with helper T cells, naïve B cell activation needs a third
signal, which is induced upon recognition of a context that signals microbial invasion.
This finding demonstrates that context discrimination via TLR triggering plays a
general role in induction of immune responses and acts on both the humoral and
cellular branch of the immune system.
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